Cover
Cover - USD ($) | 12 Months Ended | ||
Jul. 31, 2023 | Nov. 13, 2023 | Jan. 31, 2023 | |
Cover [Abstract] | |||
Entity Registrant Name | BODY AND MIND INC. | ||
Entity Central Index Key | 0001715611 | ||
Document Type | 10-K | ||
Amendment Flag | false | ||
Entity Voluntary Filers | No | ||
Current Fiscal Year End Date | --07-31 | ||
Entity Well Known Seasoned Issuer | No | ||
Entity Small Business | true | ||
Entity Shell Company | false | ||
Entity Emerging Growth Company | true | ||
Entity Current Reporting Status | Yes | ||
Document Period End Date | Jul. 31, 2023 | ||
Entity Filer Category | Non-accelerated Filer | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2023 | ||
Entity Ex Transition Period | true | ||
Entity Common Stock Shares Outstanding | 146,636,974 | ||
Entity Public Float | $ 9,147,980 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Fin Stmt Error Correction Flag | false | ||
Entity File Number | 000-55940 | ||
Entity Incorporation State Country Code | NV | ||
Entity Tax Identification Number | 98-1319227 | ||
Entity Address Address Line 1 | 750 – 1095 West Pender Street | ||
Entity Address City Or Town | Vancouver | ||
Entity Address Country | CA | ||
Entity Address Postal Zip Code | V6E 2M6 | ||
City Area Code | 800 | ||
Auditor Name | Sadler, Gibb & Associates, LLC | ||
Auditor Location | Draper, UT | ||
Auditor Firm Id | 3627 | ||
Local Phone Number | 361-6312 | ||
Security 12g Title | Common Shares, $0.0001 par value | ||
Entity Interactive Data Current | Yes |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
Current | ||
Cash | $ 1,511,051 | $ 1,469,099 |
Accounts receivable, net | 591,291 | 438,839 |
Interest receivable on convertible loan (Note 6) | 294,000 | 222,000 |
Prepaids | 542,400 | 558,135 |
Inventory (Note 5) | 2,310,601 | 3,565,431 |
Loan receivable (Note 7) | 0 | 789,984 |
Assets held for sale - discontinued operations (Note 19) | 4,030,628 | 5,942,404 |
Total Current Assets | 9,279,971 | 12,985,892 |
Deposit | 72,617 | 113,828 |
Convertible loan receivable (Note 6) | 1,700,411 | 1,250,000 |
Property and equipment, net (Note 8) | 1,827,215 | 3,720,284 |
Operating lease right-of-use assets (Note 13) | 4,329,634 | 3,271,685 |
Brand and licenses, net (Note 10) | 3,999,932 | 9,684,174 |
TOTAL ASSETS | 21,209,780 | 31,025,863 |
Current | ||
Bank overdraft | 509,937 | 0 |
Accounts payable | 2,764,672 | 2,181,937 |
Accrued liabilities | 462,025 | 325,385 |
Income taxes payable | 1,997,701 | 3,021,539 |
Due to related parties (Note 11) | 93,481 | 163,862 |
Loans payable (Note 12) | 166,001 | 12,535 |
Current portion of operating lease liabilities (Note 13) | 1,099,888 | 456,668 |
Liabilities related to assets held for sale - discontinued operations (Note 19) | 579,299 | 1,154,082 |
Total Current Liabilities | 7,673,004 | 7,316,008 |
Long-term operating lease liabilities (Note 13) | 7,858,817 | 4,816,038 |
Loans payable (Note 12) | 7,779,659 | 7,393,636 |
Convertible debentures - related parties, net (Note 12) | 2,480,522 | 0 |
Income tax payble | 4,757,387 | 966,992 |
Deferred tax liability | 0 | 427,770 |
TOTAL LIABILITIES | 30,549,389 | 20,920,444 |
STOCKHOLDERS' EQUITY | ||
Capital Stock- Statement 3 (Note 14) Authorized: 900,000,000 Common Shares - Par Value $0.0001 Issued and Outstanding: 146,636,974 (31 July 2022-113,668,613) | 14,663 | 11,366 |
Additional paid-in capital | 55,057,531 | 52,344,573 |
Shares to be issued | 0 | 1,853,403 |
Accumulated other comprehensive income | 1,482,567 | 1,224,093 |
Accumulated Deficit | (66,829,507) | (45,803,026) |
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) ATTRIBUTABLE TO BAM STOCKHOLDERS | (10,274,746) | 9,630,409 |
NON-CONTROLLING INTEREST | 935,137 | 475,010 |
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) | (9,339,609) | 10,105,419 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ 21,209,780 | $ 31,025,863 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Jul. 31, 2023 | Jul. 31, 2022 |
Consolidated Balance Sheets | ||
Common stock, shares authorized | 900,000,000 | 900,000,000 |
Common stock, par value per share | $ 0.0001 | $ 0.0001 |
Common stock, shares issued | 146,636,974 | 113,668,613 |
Common Stock, shares outstanding | 146,636,974 | 113,668,613 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Consolidated Statements of Operations and Comprehensive Loss | ||
Sales | $ 22,819,983 | $ 23,372,823 |
Cost of sales | (17,044,221) | (15,925,892) |
Gross profit | 5,775,762 | 7,446,931 |
Operating Expenses | ||
Accounting and legal | 1,315,666 | 845,386 |
Business development | 835,326 | 669,471 |
Consulting fees | 822,743 | 967,860 |
Depreciation and amortization | 1,114,508 | 1,062,797 |
Lease expense | 1,283,987 | 691,321 |
Licenses, utilities and office administration | 4,007,588 | 3,570,351 |
Management fees | 350,766 | 559,937 |
Salaries and wages | 3,715,117 | 3,591,810 |
Total Operating Expenses | (13,445,701) | (11,958,933) |
Net Operating Loss | (7,669,939) | (4,512,002) |
Other Income (Expenses) | ||
Foreign exchange, net | 1,499 | 323 |
Gain on fair value adjustment of convertible loan (Note 6) | 450,411 | 0 |
Interest expense | (1,718,859) | (1,371,330) |
Interest income | 72,000 | 72,000 |
Loss on impairment of long-lived assets (Notes 8, 10 and 13) | (9,370,093) | (20,517,192) |
Loss on settlement | 0 | (460,001) |
Other income | 80,777 | 147,457 |
Total Other Expenses | (10,484,265) | 22,128,743 |
Net Loss Before Income Tax | (18,154,204) | (26,640,745) |
Income tax expense | (2,168,486) | (1,774,609) |
Net Loss from Continuing Operations | (20,322,690) | (28,415,354) |
Discontinued Operations | ||
Net income (loss) from discontinued operations | (553,789) | 187,250 |
Gain on sale of NMG MI 1, LLC | 310,125 | 0 |
Net Income (Loss) from Discontinued Operations | (243,664) | 187,250 |
Net Loss | (20,566,354) | (28,228,104) |
Other Comprehensive Income | ||
Foreign currency translation adjustment | 258,474 | 96,380 |
Comprehensive Loss | (20,307,880) | (28,131,724) |
Net income (loss) from continuing operations attributable to: | ||
Body and Mind Inc. | (20,782,817) | (28,863,766) |
Non-controlling interest | 460,127 | 448,412 |
Net income (loss) attributable to: | ||
Body and Mind Inc. | (21,026,481) | (28,676,516) |
Non-controlling interest | 460,127 | 448,412 |
Comprehensive loss attributable to: | ||
Body and Mind Inc. | (20,768,007) | (28,580,136) |
Non-controlling interest | $ 460,127 | $ 448,412 |
Loss per share attributable to Body and Mind Inc. - Basic and Diluted: | ||
Continuing operations | $ (0.15) | $ (0.26) |
Discontinued operations | 0 | 0.01 |
Loss per share attributable to Body and Mind Inc. - Basic and Diluted | $ (0.15) | $ (0.25) |
Weighted Average Number of Shares Outstanding - Basic and Diluted | 134,345,873 | 112,209,254 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Stockholders Equity (Deficit) - USD ($) | Total | Common Stock | Additional Paid-In Capital | Shares To Be Issued Member | Accumulated other comprehensive loss | Retained Earnings (Accumulated Deficit) | Noncontrolling Interest |
Balance, amount at Jul. 31, 2021 | $ 34,350,721 | $ 10,907 | $ 50,312,013 | $ 0 | $ 1,127,713 | $ (17,126,510) | $ 26,598 |
Balance, shares at Jul. 31, 2021 | 109,077,778 | ||||||
Common stock issued in acquisition of Canopy shares | 2,728,156 | ||||||
Common stock issued in acquisition of Canopy, amount | 2,792,723 | $ 273 | 939,047 | 1,853,403 | 0 | 0 | 0 |
Common stock issued for operating leases (Note 15) shares | 1,862,679 | ||||||
Common stock issued for operating leases (Note 15) amount | 578,848 | $ 186 | 578,662 | 0 | 0 | 0 | 0 |
Warrants issued for loan amendment (Note 14) | 79,585 | 0 | 79,585 | 0 | 0 | 0 | 0 |
Stock-based compensation (Note 14) | 435,266 | 0 | 435,266 | 0 | 0 | 0 | 0 |
Foreign currency translation adjustment | 96,380 | 0 | 0 | 0 | 96,380 | 0 | 0 |
Loss for the year | (28,228,104) | $ 0 | 0 | 0 | 0 | (28,676,516) | 448,412 |
Balance, shares at Jul. 31, 2022 | 113,668,613 | ||||||
Balance, amount at Jul. 31, 2022 | 10,105,419 | $ 11,366 | 52,344,573 | 1,853,403 | 1,224,093 | (45,803,026) | 475,010 |
Common stock issued in acquisition of Canopy shares | 16,301,694 | ||||||
Common stock issued in acquisition of Canopy, amount | $ 1,630 | 1,851,773 | (1,853,403) | 0 | 0 | 0 | |
Stock-based compensation (Note 14) | 270,693 | 0 | 270,693 | 0 | 0 | 0 | 0 |
Foreign currency translation adjustment | 258,474 | 0 | 0 | 0 | 258,474 | 0 | 0 |
Loss for the year | (20,566,354) | $ 0 | 0 | 0 | 0 | (21,026,481) | 460,127 |
Common stock issued in merger of CraftedPlants NJ, shares | 16,666,667 | ||||||
Common stock issued in merger of CraftedPlants NJ, amount | $ 1,667 | (1,667) | 0 | 0 | 0 | 0 | |
Warrants issued in convertible debentures financing | 592,159 | $ 0 | 592,159 | 0 | 0 | 0 | 0 |
Balance, shares at Jul. 31, 2023 | 146,636,974 | ||||||
Balance, amount at Jul. 31, 2023 | $ (9,339,609) | $ 14,663 | $ 55,057,531 | $ 0 | $ 1,482,567 | $ (66,829,507) | $ 935,137 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Operating Activities | ||
Net loss from continuing operations | $ (20,322,690) | $ (29,159,677) |
Items not affecting cash: | ||
Accrued interest and accretion | 458,703 | 948,909 |
Accrued interest income | (72,000) | (72,000) |
Amortization of intangible assets | 1,021,260 | 986,906 |
Operating lease costs | 669,276 | 438,470 |
Depreciation | 781,033 | 821,284 |
Deferred tax expense | (427,770) | 229,431 |
Gain on fair value adjustment of convertible loan | (450,411) | 0 |
Loss on impairment of long-lived assets | 9,370,093 | 20,517,192 |
Loss on settlement of contingent consideration | 0 | 503,179 |
Gain on settlement of lease liabilities | 0 | (43,178) |
Stock-based compensation | 270,693 | 435,266 |
Accounts receivable and prepaids | (136,717) | 1,160,729 |
Inventory | 1,254,830 | (200,230) |
Deposits | 41,211 | (113,828) |
Trade payables and accrued liabilities | 791,661 | 491,817 |
Income taxes payable and deferred taxes | 2,766,557 | (1,072,760) |
Due to related parties | (70,381) | 111,788 |
Lease liabilities | (718,414) | (775,307) |
Cash used in operating activities from continuing operations | (4,773,066) | (4,792,009) |
Cash provided by operating activities from discontinued operations | 939,660 | 1,347,731 |
Cash used in operating activities | (3,833,406) | (3,444,278) |
Investing Activities | ||
Acquisition of Canopy, net of cash received | 0 | (871,497) |
Purchase of property and equipment | (992,884) | (264,513) |
Loan receivable | 938,205 | (391,168) |
Cash used in investing activities from continuing operations | (54,679) | (1,527,178) |
Cash provided by (used in) investing activities from discontinued operations | (19,800) | (618,308) |
Cash provided by (used in) investing activities | (74,479) | (2,145,486) |
Financing Activities | ||
Bank overdraft | 509,937 | 0 |
Proceeds from (repayment of) loans payable, net | 5,245 | (26,533) |
Proceeds from convertible debenture financing | 3,000,000 | 0 |
Cash provided by (used in) financing activities from continuing operations | 3,515,182 | (26,533) |
Effect of exchange rate changes on cash | 258,474 | 96,380 |
Increase (decrease) in cash for the year | (134,229) | (5,519,917) |
Cash transferred to assets held for sale | 176,181 | (114,449) |
Cash- beginning of year | 1,469,099 | 7,103,465 |
Cash- end of year | $ 1,511,051 | $ 1,469,099 |
Nature and Continuance of Opera
Nature and Continuance of Operations | 12 Months Ended |
Jul. 31, 2023 | |
Nature and Continuance of Operations | |
Nature and Continuance of Operations | 1. Nature and Continuance of Operations Body and Mind Inc. (the “Company”) was incorporated on 5 November 1998 in the State of Delaware, USA, under the name Concept Development Group, Inc. In May 2004, the Company acquired 100% of Vocalscape, Inc. and changed its name to Vocalscape, Inc. On October 28, 2005, the Company changed its name to Nevstar Precious Metals Inc. On October 23, 2008, the Company changed its name to Deploy Technologies Inc. (“Deploy Tech”) and, on September 15, 2010, the Company incorporated a wholly-owned subsidiary, Deploy Acquisition Corp. (“Deploy”) under the laws of the State of Nevada, USA. On September 17, 2010, the Company merged with and into Deploy under the laws of the State of Nevada. Deploy, as the surviving corporation of the merger, assumed all the assets, obligations and commitments of Deploy Tech, and we were effectively re-domiciled in the State of Nevada. Upon the completion of the merger, Deploy assumed the name “Deploy Technologies Inc.”, and all of the issued and outstanding common stock of Deploy Tech was automatically converted into and became Deploy’s issued and outstanding common stock. On 14 November 2017, the Company acquired Nevada Medical Group, LLC (“NMG”) and changed its name to Body and Mind Inc. The Company is now a supplier and grower of medical and recreational cannabis in the state of Nevada, and has retail operations in California, Ohio, and Arkansas. Principles of Consolidation These consolidated financial statements include the financial statements of the Company and its subsidiaries as follows: Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100 % 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100 % 14 November 2017 NMG Long Beach LLC (“NMG LB”) California, USA 100 % 18 December 2018 NMG San Diego LLC (“NMG SD”) California, USA 60 % 30 January 2019 NMG Ohio LLC (“NMG Ohio”) Ohio, USA 100 % 27 April 2017 NMG OH 1, LLC (“NMG OH 1”) Ohio, USA 100 % 30 January 2020 NMG OH P1, LLC (“NMG OH P1”) Ohio, USA 100 % 30 January 2020 NMG MI 1, Inc. (“NMG MI 1”) Michigan, USA 100 % 24 June 2021 NMG MI C1 Inc. Michigan, USA 100 % 24 June 2021 NMG MI P1 Inc. Michigan, USA 100 % 24 June 2021 Canopy Monterey Bay, LLC (“Canopy”) California, USA 100 % 30 November 2021 NMG CA P1, LLC (“NMG CA P1”) California, USA 100 % 7 January 2020 NMG CA C1, LLC (“NMG CA C1”) California, USA 100 % 7 October 2020 BaM Body and Mind Dispensary NJ, Inc. (“BAM NJ”) New Jersey, USA 100 % 21 December 2022 NMG IL4, LLC (“NMG IL 4”) Illinois, USA 100 % 25 April 2023 All inter-company transactions and balances are eliminated upon consolidation. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 12 Months Ended |
Jul. 31, 2023 | |
Recent Accounting Pronouncements | |
Recent Accounting Pronouncements | 2. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows. |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Jul. 31, 2023 | |
Significant Accounting Policies | |
Significant Accounting Policies | 3. Significant Accounting Policies The following is a summary of significant accounting policies used in the preparation of these consolidated financial statements. Basis of presentation These condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July. Accounts receivable Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As of 31 July 2023 and 2022, the Company has no allowance for doubtful accounts. Revenue recognition The Company recognizes revenue from product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement for wholesale operations. Upon transfer of control, the Company has no further performance obligations. All retail sales are considered cash on delivery. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration. See Note 15 for revenue disaggregation table. Inventory and cost of goods sold Inventory consists of work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost using the average cost method. Costs incurred during the growing and production process are capitalized as incurred to the extent that cost is less than net realizable value. These costs include materials, labor and manufacturing overhead used in the growing and production processes. The Company capitalizes pre-harvest costs. The Company periodically reviews its inventory for obsolete and potentially impaired items. Any identified slow moving and obsolete items are written down to its net realizable value through a charge to cost of goods sold. As of 31 July 2023 and 2022, the Company has no allowance for inventory obsolescence. Cost of goods sold includes the costs directly attributable to product sales and includes amounts paid for finished goods, such as flower, edibles and concentrates, packaging and other supplies, fees for services and processing, and allocated overhead, such as allocations of rent, administrative salaries, utilities and related costs. Loans receivable The Company carries its loans receivable at cost and are reviewed for indicators of impairment at least annually. Property and equipment Property and equipment are stated at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease Intangible assets Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses acquired from NMG have indefinite lives; therefore, no amortization is recognized. The Company’s brands and licenses acquired by NMG SD have a finite life of 10 years, brands and licenses acquired by NMG LB and NMG OH 1 have a finite life of 10 years, customer relationships acquired by NMG OH 1 have a finite life of five years, licenses acquired by Canopy have a finite life of 10 years and are amortized over these estimated useful lives on a straight-line basis. Brands acquired by Canopy have indefinite lives. Impairment of long-lived assets The Company reviews long-lived assets, including property and equipment and definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Impairment of goodwill and indefinite-lived assets Goodwill and indefinite-lived intangible assets are not amortized. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying amount in accordance with the provisions of ASC 350, “Intangibles—Goodwill and Other”. The Company performs an impairment test annually by comparing the fair value of the indefinite-lived intangible assets or reporting unit (for goodwill) with its carrying amount. The measurement of the impairment loss to be recognized is based on the amount by which the carrying amount exceeds the reporting unit’s fair value. Income taxes Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of operations and comprehensive income. Basic and diluted net income (loss) per share The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. As of 31 July 2023, potential common shares are comprised of 17,151,000 outstanding options, 33,215,284 outstanding warrants and 31,472,877 shares issuable on conversion of convertible debentures. Comprehensive loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the consolidated financial statements. As of 31 July 2023 and 2022, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements. Foreign currency translation The Company’s functional currency is the Canadian dollar and its reporting currency is in U.S. dollars. The Company’s subsidiaries have a functional currency in U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. The exchange rates used to translate Canadian dollar to U.S. dollar was 0.7589 for monetary assets and liabilities and 0.7455 as an average rate for transactions occurred during the year ended 31 July 2023. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of net loss. Stock-based compensation The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur. Fair value measurements The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. The convertible loan receivable was valued using Level 3 inputs. Other current financial assets and current financial liabilities have fair values that approximate their carrying values. Use of estimates and assumptions The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities, if any, at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates. Lease accounting Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that does not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment. Non-controlling Interest Non-controlling interests (“NCI”) represent equity interests owned by outside parties. NCI may be initially measured at fair value or at the NCI’s proportionate share of the recognized amounts of the acquiree's identifiable net assets. The choice of measurement is made on a transaction-by-transaction basis. The Company has elected to measure each NCI at its proportionate share of the recognized amounts of the acquiree’s identifiable net assets. The share of net assets attributable to NCI are presented as a component of equity. NCI's share of net income or loss is recognized directly in equity. Total income or loss of subsidiaries is attributed to the shareholders of the Company and to the NCI, even if this results in the NCI having a deficit balance. Assets and liabilities held for sale The Company classifies assets held for sale in accordance with ASC 360, “Property, Plant and Equipment”. When the Company makes the decision to sell an asset or to stop some part of its business, the Company assesses if such assets should be classified as an asset held for sale. To classify as an asset held for sale, the asset or disposal group must meet all of the following conditions: i) management, having the authority to approve the action, commits to a plan to sell the asset, ii) the asset is available for immediate sale in its present condition subject to certain customary terms, iii) an active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated, iv) the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale, within one year, subject to certain exceptions, v) the asset is being actively marketed for sale at a price that is reasonable in relation to its current value, and vi) actions required to complete the plan indicate that it is unlikely that the plan will be significantly changed or withdrawn. Assets held for sale are measured at the lower of their carrying amount or fair value less cost to sell (“FVLCTS”). FVLCTS is the amount obtainable from the sale of the asset in an arm’s length transaction, less the costs of disposal. Once classified as held for sale, any depreciation and amortization on an asset cease to be recorded. For long-lived assets or disposals groups that are classified as held for sale but do not meet the criteria for discontinued operations, the assets and liabilities are presented separately on the balance sheet of the initial period in which it is classified as held for sale. The major classes of assets and liabilities classified as held for sale are disclosed in the notes to the consolidated financial statements. |
Financial Instruments
Financial Instruments | 12 Months Ended |
Jul. 31, 2023 | |
Financial Instruments | |
Financial Instruments | 4. Financial Instruments The following table represents the Company’s assets that are measured at fair value as of 31 July 2023 and 2022: As of 31 July 2023 As of 31 July 2022 Financial assets at fair value Cash $ 1,511,051 $ 1,854,277 Convertible loan receivable 1,700,411 1,250,000 Total financial assets at fair value $ 3,211,462 $ 3,104,277 Management of financial risks The financial risk arising from the Company’s operations include credit risk, liquidity risk, interest rate risk and currency risk. These risks arise from the normal course of operations and all transactions undertaken are to support the Company’s ability to continue as a going concern. The risks associated with these financial instruments and the policies on how to mitigate these risks are set out below. Management manages and monitors these exposures to ensure appropriate measures are implemented on a timely and effective manner. Credit risk Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company reduces its exposure to credit risk by maintaining its cash with major financial institutions. Credit risk associated with the convertible loans receivable arises from the possibility that the principal and/or interest due may become uncollectible. The Company mitigates this risk by managing and monitoring the underlying business relationship. Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company ensures, as far as reasonably possible, that it will have sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and the Company’s holdings of cash. The Company had working capital of $1,606,967 at 31 July 2023, however, the Company had recurring net losses and negative cash flows from operations, and the Company required additional financing to meet all current and future financial obligations which caused substantial doubt about its ability to continue as a going concern for a period of one year from the issuance of these financial statements. The Company anticipates that cash on hand and working capital will ensure coverage for all expenses associated with current operations for at least the next 12 months from the issuance of these financial statements. Management believes that the Company has access to capital resources through potential public or private issuances of debt or equity securities to further contribute to the growth. Interest rate risk Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to interest rate risk as it does not hold financial instruments that will fluctuate in value due to changes in interest rates. Currency risk Currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company is exposed to currency risk by incurring expenditures and holding assets denominated in currencies other than its functional currency. |
Inventory
Inventory | 12 Months Ended |
Jul. 31, 2023 | |
Inventory | |
Inventory | 5. Inventory 31 July 2023 31 July 2022 Work in progress $ 652,825 $ 610,030 Finished goods 604,519 1,961,244 Consumables 1,053,257 1,308,726 Total $ 2,310,601 $ 3,880,000 |
Convertible loan receivable
Convertible loan receivable | 12 Months Ended |
Jul. 31, 2023 | |
Convertible loan receivable | |
Convertible loan receivable | 6. Convertible loan receivable Effective March 15, 2019, the Company, through its wholly owned subsidiaries, DEP Nevada and NMG, entered into a convertible loan agreement and a management agreement with Comprehensive Care Group LLC (“CCG”), an Arkansas limited liability company, with respect to the development of a medical cannabis dispensary facility in West Memphis, Arkansas. The convertible loan agreement can be extended by either party and the current agreement has a maturity date of 30 March 2024. Under no circumstances the maturity date of the convertible loan agreement shall extend beyond the expiration of the management agreement as described below. Pursuant to the management agreement, NMG will provide operations and management services, including management, staffing, operations, administration, oversight, and other related services. Under the management agreement, NMG will be required to obtain approval from CCG for any key decisions as defined in the agreement and accordingly the Company does not control CCG. NMG will be paid a monthly management fee equal to 66.67% of the monthly net profits of CCG, subject to conversion of the convertible loan as discussed below upon which the monthly management fee shall be $6,000 per month, unless otherwise agreed by the parties in writing. The management agreement has an expiration of 15 March 2024 and can be mutually extendable. The convertible loan agreement is for an amount up to $1,250,000 from DEP to CCG with proceeds to be used to fund construction of a facility, working capital and initial operating expenses. The loan bears interest at a fixed rate of $6,000 per month until the parties mutually agree to increase the interest. Upon the latter of one year of granting of a medical cannabis dispensary license by the appropriate authorities or one year after entering into the convertible loan agreement, DEP may elect to convert the loan into preferred units of CCG equal to 40% of all outstanding preferred units of CCG that carry 66.7% voting interest, subject to approval of the Arkansas Medical Marijuana Commission. The Company had advanced $1,250,000 (2022 - $1,250,000) at 31 July 2023, and accrued interest income of $72,000 (2022 - $72,000) and for year ended 31 July 2023, respectively. As of 31 July 2023, total interest receivable was $294,000 (2022 - $222,000). The Company evaluated the convertible loan receivable’s settlement provisions and elected the fair value option in accordance with ASC 825 “Financial Instruments”, to value this instrument. Under such election, the loan receivable is measured initially and subsequently at fair value, with any changes in the fair value of the instrument being recorded in the consolidated financial statements as a change in fair value of the financial instruments. The Company estimates the fair value of this instrument by first estimating the fair value of the straight debt portion, excluding the embedded conversion option, using a discounted cash flow model. The Company then estimates the fair value of the embedded conversion option using the Black-Scholes Option Pricing Model. The discounted cash flow model for the straight debt portion uses four different scenarios as follows: The Company discounts the principal amount of $1,250,000, monthly interest payment of $6,000 using these four different maturity dates: (1) March 30, 2024, (2) March 30, 2025, (3) March 30, 2026 and (4) March 30, 2027, whereby each scenario is given 25% probability of occurring since the actual conversion date is uncertain. The discount rate used is 23.23%. The assumptions used in the Black-Scholes Option Pricing Model for the conversion option are as follows: (i) equity price of $38,335 per unit calculated as BAM’s portion of the future projected profits, on a per unit basis, discounted using Weighted Average Cost of Capital of 15%; (ii) exercise price of $31,250 per unit as there are 40 units in total, (iii) volatility of 90% using BAM as benchmark, (iv) expected life of 2.20 years and (v) risk-free rate of 4.74%. The sum of these two valuation models resulted in an estimated fair value of the loan receivable balance of $1,700,411 as of 31 July 2023. The change in the fair value of the convertible loan receivable has been recorded as a gain on fair value adjustment of convertible loan during the year ended 31 July 2023. |
Loan receivable
Loan receivable | 12 Months Ended |
Jul. 31, 2023 | |
Loan receivable | |
Loan receivable | 7. Loan receivable In addition to the convertible loan receivable (Note 6), the Company provides operating loans to CCG that are non-interest bearing, unsecured and due on demand. During the year ended 31 July 2023, the Company advanced $1,480,021 (2022 - $1,234,168) to CCG and received repayments totaling $2,418,226 (2022 - $843,000) for a net decrease in loan receivable of $938,206 (2022 – net increase of $391,168). At 31 July 2023, the net amount payable to CCG was $148,221 (2022 – receivable of $789,984). See also Note 12. |
Property and Equipment
Property and Equipment | 12 Months Ended |
Jul. 31, 2023 | |
Property and Equipment | |
Property and Equipment | 8. Property and Equipment Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Total Cost: Balance, 31 July 2022 $ 333,689 $ 466,110 $ 581,335 $ 63,102 $ 38,717 $ 10,335 $ 4,487,002 $ 5,980,290 Additions 25,183 - - - - - 967,701 992,884 Impairment (295,980 ) (466,110 ) (345,650 ) (41,050 ) (38,717 ) (2,172 ) (3,304,042 ) (4,493,721 ) Balance, 31 July 2023 62,892 - 235,685 22,052 - 8,163 2,150,661 2,479,453 Accumulated Depreciation: Balance, 31 July 2022 61,761 318,856 290,729 29,880 29,859 3,266 1,525,654 2,260,005 Depreciation 49,469 68,312 81,322 9,014 5,531 1,476 565,909 781,033 Impairment (85,525 ) (387,168 ) (251,572 ) (26,285 ) (35,390 ) (1,828 ) (1,601,032 ) (2,388,800 ) Balance, 31 July 2023 25,705 - 120,479 12,609 - 2,914 490,531 652,238 Net Book Value: At 31 July 2022 271,928 147,254 290,606 33,222 8,858 7,069 2,961,348 3,720,285 At 31 July 2023 $ 37,187 $ - $ 115,206 $ 9,443 $ - $ 5,249 $ 1,660,130 $ 1,827,215 For the year ended 31 July 2023, a total depreciation of $93,248 (2022 - $223,764) was included in General and Administrative Expenses and a total depreciation of $687,785 (2022 - $745,393) was included in Cost of Sales. Based on the fact that the NMG MI 1 was disposed of at a nominal amount in accordance with the Stock Purchase Agreement (Note 19), the fair value of the asset group of NMG MI 1 was $nil resulting in an impairment of $944,015 during the year ended 31 July 2023 included in discontinued operations. In addition, the operational results of NMG and NMG LB were lower than expected. As a result, the Company impaired property and equipment of NMG and NMG LB resulting in a loss of $2,104,921 during the year ended 31 July 2023. |
Acquisitions
Acquisitions | 12 Months Ended |
Jul. 31, 2023 | |
Acquisitions | |
Acquisitions | 9. Acquisitions Canopy Monterey Bay, LLC – Business Acquisition On 30 November 2021, the Company entered into two definitive agreements with Canopy Monterey Bay, LLC (“Canopy”) and the membership interest owners (the “Sellers”) of Canopy to acquire an aggregate of 100% of Canopy, which owns a retail dispensary in the limited license jurisdiction of Seaside, California, to expand our retail operations. The first purchase agreement (“PA #1”) between DEP and Canopy and all of the Sellers provides for the assignment of 80% of the membership interests of Canopy to DEP in exchange for a purchase price of $4,800,000 comprised of $2,500,000 in cash (the “Cash Purchase Price”) and a secured promissory note in the amount of $2,300,000 bearing interest at a rate of 10% per annum compounded annually and having a maturity date of five years from the effective date of PA #1. Interest is payable for the first 6 months with the principal and accrued interest due at maturity. There are no prepayment penalties. The Cash Purchase Price is to be paid into escrow pursuant to an escrow agreement between the parties to PA #1 and Secured Trust Escrow, which Cash Purchase Price is to be released to the Sellers upon the receipt of city and state approval and completion of the audited annual financial statements (the “Financial Statements”) of Canopy, or returned to DEP in the event of the denial of city or state approval or failure to complete the Financial Statements and the agreement is terminated, in which case the 80% membership interests will be transferred back to the Sellers and the promissory note will automatically be terminated. As of the date hereof, the city and state approvals have been received and the formal closing of the purchase of the 80% of the membership interests in Canopy closed in June 2022. The second purchase agreement (“PA #2”) between DEP and the one continuing Seller provides for the assignment of the remaining 20% of the membership interests of Canopy to DEP following the receipt of the city and state approval and completion of the Financial Statements under PA #1 in exchange for $1,000,000 to be paid in either shares of common stock of the Company (the “Consideration Shares”) or in cash at DEP’s sole option if such payment takes place within six (6) months following the execution of PA #1. If DEP elects to pay the purchase price in Consideration Shares, the amount of Consideration Shares shall be determined based on the 10 day volume weighted average price (“VWAP”) ending on 30 November 2021, which is US$0.3665 per share for a total of 2,728,156 shares (issued) (Note 14). In the event that six (6) months following the execution of PA #1, the value of the Consideration Shares have decreased such that total value of the Consideration Shares is less than ninety percent (90%) of its value, DEP agrees to cause the Company to issue an additional $100,000 worth of shares of common stock of the Company (the “Additional Shares”) to be issued to the one continuing Seller based on the ten day VWAP calculated as of six (6) months following the closing of PA #1. This was included as contingent consideration in the purchase price and $100,000 was recorded in accounts payable at 31 July 2022. PA #2 contains a working capital adjustment provision, which provides that if there is a working capital deficiency as of the closing date of PA #1, then the purchase price under PA #2 shall be reduced by the amount of the deficiency, and if there is a working capital surplus as of the closing date of PA #1, then the purchase price under PA #2 shall be increased by the amount of the surplus. On or around 1 December 2021, 80% of the membership interests of Canopy were transferred to DEP for purposes of applying for city and state approvals of the change in ownership of Canopy, however, the purchase price consideration of (i) $2.5 million in cash, and (ii) a promissory note in the amount of $2.3 million to be paid by DEP, were placed in escrow and not to be released to the sellers of the 80% membership interests in Canopy until the city and state approvals have been received and the Financial Statements of Canopy are completed. If the city or state approvals are not received, or the Financial Statements of Canopy are not completed, then the Buyer may terminate the membership interest purchase agreement requiring the membership interests in Canopy to be transferred back to the sellers and the escrow agent to deliver back to DEP the cash consideration and the promissory note shall automatically be terminated. As of the date hereof, the city and state approvals have been received and the formal closing of the purchase of the 80% membership interests in Canopy closed in June 2022. On 17 June 2022, the Company, through its wholly owned subsidiary, DEP Nevada, Inc., entered into the first amendment to PA #1 and PA #2 (the “First Amendment”) whereby the cash purchase price under PA #1 will be reduced from $2.5 million to $1.25 million and the Company will issue $1.25 million in shares of common stock of the Company to the Sellers based on the 10 day volume weighted average price (“VWAP”) for the ten (10) consecutive trading days prior to the effective date of the First Amendment (the “Effective Date”) and subject to compliance with the policies of the Canadian Securities Exchange (the “CSE”), which equates to 9,328,358 shares of common stock. The Company will also issue additional shares to Cary Stiebel equal to the difference between the amount of the shares of common stock of the Company that were issued by the Company to Mr. Stiebel on December 3, 2021 (the “PA #2 Shares”) and the amount of shares that Mr. Stiebel would have received had the VWAP for the PA #2 Shares been calculated as of the Effective Date (the “Additional PA #2 Shares”) which equates to 4,734,530 shares of common stock. Additionally, on the date that is eighteen (18) months (548 days) following the Effective Date of this First Amendment (the “Additional Share Issuance Date”) the Company will issue $100,000 worth of shares to the Sellers based on the ten (10) day VWAP and subject to compliance with the policies of the CSE, calculated as of the Additional Share Issuance Date. This $100,000 was recorded as consulting fees for the year ended 31 July 2022. Furthermore, DEP shall cause the Company to issue to Mr. Stiebel $300,000 worth of shares of common stock of the Company within three (3) days following the Effective Date of this First Amendment, and subject to compliance with the policies of the CSE (the “Additional True up Shares”) which equates to 2,238,806 shares of common stock. Prior to the conclusion of the calculation of the actual working capital in accordance with PA #1 and PA #2, Sellers shall complete, execute and deliver to DEP Schedule D to the First Amendment, which shall set forth the amount of Additional True-up Shares each Seller is entitled to (as applicable) and such Additional True-up Shares shall be retitled in accordance with Schedule D to the First Amendment. In the event Schedule D to the First Amendment is not completed, executed and delivered to DEP prior to the conclusion of the calculation of the actual working capital, DEP shall have no obligation to retitle the shares and all Sellers hereby waive any claims against DEP and the Company in connection with such issuance made in accordance with Section 2(b)(v) of the First Amendment. Upon conclusion of the calculation of the actual working capital in accordance with PA #1 and PA #2, the parties agree as follows: (a) If the actual working capital is less than the target working capital of $nil, the Purchase Price (as defined in PA #2) shall be reduced by an amount equal to the difference between the target working capital and the actual working capital and all of the Additional True-up Shares shall be forfeited and retuned to Company for cancellation; (b) If the actual working capital is greater than the target working capital of $nil and the Additional True-up Shares are sufficient to cover the difference between the actual working capital and the target working capital (the “DEP Deficit”), the parties agree that all or a portion of the Additional True-up Shares (valued at the ten (10) day VWAP calculated as of the Effective Date of the First Amendment and subject to compliance with the policies of the CSE) shall be issued to Sellers to satisfy the DEP Deficit owed by DEP to the Sellers in accordance with Section 2.02(b) of PA #2; (c) If the actual working capital is greater than the target working capital and the Additional True-up Shares are insufficient to cover the DEP Deficit, all of the Additional True-up Shares shall be issued to Sellers and the parties agree that any additional amounts owed to the Sellers shall be paid by DEP to the Sellers via additional shares of common stock of the Company. In addition to the terms of the First Amendment, the parties have agreed that the release of any Additional True-up Shares hereunder shall be subject to the Sellers providing written direction to DEP for the release of the Additional True-up Shares payable under the First Amendment. On December 7, 2022, pursuant to the previously announced (i) membership interest purchase agreement (“MIPA #1”), dated November 30, 2021, as amended on June 17, 2022, entered into between the Company’s wholly-owned subsidiary, DEP Nevada, Inc. (“DEP”), Canopy Monterey Bay, LLC (“Canopy”) and the membership interest owners of Canopy, Carey Stiebel (the “Continuing Owner”), Jana Stiebel, Jayme Rivard, Adrian Dermicek and Laurie Johnson (collectively, the “Sellers”) to purchase eighty percent (80%) of the issued and outstanding membership interests of Canopy, and (ii) membership interest purchase agreement (“MIPA #2”), dated November 30, 2021, as amended on June 17, 2022, entered into between DEP and the Continuing Owner to purchase the remaining twenty percent (20%) of the issued and outstanding membership interests of Canopy, the Company through DEP completed the acquisition of all of the membership interests of Canopy from the Sellers and closed MIPA #1, as amended, and MIPA #2, as amended. Pursuant to the closing of MIPA #1, as amended, and MIPA #2, as amended, the Company issued an aggregate of 16,301,694 shares of common stock to the Sellers in accordance with their instructions at a deemed price of US$0.134 per share. 2,238,806 of the 16,301,694 shares are being held in escrow pending the results of a working capital adjustment in accordance with MIPA #1 and MIPA #2. The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. For accounting purposes, the acquisition date is the date that the Company obtained full control over the operations, although not all conditions for closing the acquisition had occurred as of 1 December 2021. The following table summarizes the fair value of the assets acquired and the liabilities assumed, which were recorded as of the acquisition date, as well as the aggregate consideration for the acquisition of Canopy made by the Company: Purchase consideration Cash $ 1,250,000 Promissory note 2,300,000 Shares of common stock (Note 14) 2,189,544 Contingent consideration 100,000 Total consideration 5,839,544 Assets acquired: Cash 378,503 Prepaid expenses 241,449 Inventory 630,039 Liabilities assumed: Trade payable and accrued liabilities (266,307 ) Income taxes payable (1,229,213 ) Net assets acquired (245,529 ) Brand and licenses 1,240,000 Goodwill 4,845,073 TOTAL $ 5,839,544 During the year ended 31 July 2022, the Company also recorded a loss on settlement of contingent consideration of $503,179 resulting from the fair value adjustment of the Company’s shares of common stock that have not been issued at 31 July 2022 and also recorded a consulting fee of $100,000 to be paid to the sellers in shares that was not included in the purchase consideration. Pro Forma The following table summarizes our consolidated results of operations for the year ended 31 July 2022 as though the acquisition of Canopy had occurred on 1 August 2021: Year ended 31 July 2022 As Reported Pro Forma (unaudited) Revenue $ 23,372,823 $ 26,661,994 Net loss (28,228,104 ) (28,212,341 ) The unaudited pro forma information set forth above is for informational purposes only and include all adjustments necessary for the fair presentation, in all material respects, of the Company’s combined operations including Canopy as if the business combinations occurred on 1 August 2021. No adjustments have been made to reflect potential cost savings that may occur subsequent to completion of the transactions. The unaudited pro forma financial information is not intended to reflect the results of operations of the Company which would have actually resulted had the proposed transaction been effected on the date indicated above. Further, the unaudited pro forma financial information is not necessarily indicative of the results of operations that may be obtained in the future. The actual pro forma adjustments will depend on a number of factors, and could result in a change to the unaudited pro forma financial information. CraftedPlants NJ Corp (“Merger”) – Asset Acquisition from a Related Party On December 21, 2022, the Company, its wholly owned subsidiary, DEP Nevada, Inc. (“DEP”), BaM Body and Mind Dispensary NJ Inc., a New Jersey corporation and wholly owned subsidiary of DEP (the “Merger Sub”), CraftedPlants NJ Corp., a New Jersey corporation (the “Surviving Entity”), an entity controlled by a Director of the Company, and those certain shareholders of the Surviving Entity (the “Sellers”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) whereby the Merger Sub merged with and into the Surviving Entity, and following the consummation of the merger, which occurred on December 21, 2022, the Surviving Entity became a wholly owned subsidiary of DEP and changed its name to BaM Body and Mind Dispensary NJ, Inc. (the “Merged Entity”). CraftedPlants NJ Corp. had a lease in Lawrenceville, New Jersey that was already zoned for cannabis retail store. There is no operational history for CraftedPlants NJ Corp. and is essentially comprised of one operating lease asset. The lease agreement does not include any provision that would revoke the approval for a cannabis retail store in a change of ownership of CraftedPlants NJ. Management is not aware of any laws and regulations that would revoke the zoning approval upon change of ownership. The purpose of the merger is expansion into the New Jersey adult use market through merging with an entity with a lease in New Jersey with local preapproval for an adult us cannabis location. The compensation for merger is contingent on success milestones including granting of pending license approval from the State of New Jersey Cannabis Regulatory Commission and opening of the business as a recreational cannabis dispensary. The Company also entered into a three-year strategic advisory services agreement with Bengal Impact Partners, LLC (“Bengal Capital”) dated 5 January 2023 (“Bengal Advisory Agreement”). The Company shall pay Bengal Capital $240,000 on each anniversary, of which $60,000 is to be paid in cash and $180,000 is to be paid in cash, common stock, or warrants to purchase shares of the Company’s common stock, in such proportions as are determined by the Company. In addition, if the Company successfully obtains a cultivation license in New Jersey during the term of the Bengal Advisory Agreement, the Company will owe a fee of $1,000,000, which will be payable in the form of the Company’s common stock or a warrant to purchase shares of the Company’s common stock, in either case as requested by Bengal Capital. Bengal Catalyst Funds and CraftedPlants NJ Corp were both owned or managed by the principals of the Bengal Capital Group and Bengal Catalyst Fund also participated in the 19 December 2022 convertible debenture financings (Note 12). Joshua Rosen is a managing principal of the Bengal Capital Group and he was involved in both transactions of the convertible note investment and the merger acquisition of Crafted Plants NJ Corp. Joshua Rosen was appointed as a director of the Company effective 1 February 2023, and therefore this transaction is considered a related party transaction. Pursuant to the terms of the Merger Agreement, on the closing DEP delivered a cash payment of $50,000 to the Sellers, with a delayed payment of approximately $120,000 to be paid to the Sellers upon funding of the project buildout which is anticipated to occur after receipt of the New Jersey state license and local construction approvals. Further, pursuant to the terms of the Merger Agreement, on December 21, 2022, the Company issued to the Sellers an aggregate of 16,666,667 shares of its common stock (the “Merger Consideration Shares”). The Merger Consideration Shares will be held in escrow and will not be released to the Sellers until the Surviving Entity achieves certain milestones, however, the Sellers will still maintain the voting and participation rights with respect to the Merger Consideration Shares while being held in escrow. The post-closing milestones are as follows: 1. If, within two (2) years of the closing date, the Surviving Entity’s application is approved and is granted pending license approval from the New Jersey Cannabis Regulatory Commission (the “CRC”), 70% of the Merger Consideration Shares will be release from escrow. 2. If, within three (3) years of the closing date, the Surviving Entity opens for business as a recreational cannabis dispensary, 30% of the Merger Consideration Shares will be released from escrow. If either or both of the milestones are not achieved within the time periods after the closing date (the “Milestone Dates”), the Company shall have the option to cancel the Merger Consideration Shares attributable to the failed milestone by delivering written notice to Sellers and in the event of such cancellation, the portion of the Merger Consideration Shares attributable to the failed milestone shall be surrendered and cancelled without any further action required by the parties. Notwithstanding the foregoing, if either or both of the milestones are not achieved (or if it becomes obvious that they will not be achieved) by their respective Milestone Dates because of delays that are not caused by the Sellers, the Sellers may, before the applicable Milestone Dates, provide notice to the Company, and the applicable Milestone Date will be extended to such date as is reasonably necessary for the milestone to be achieved. The parties will work together in mutual good faith to determine the dates by when the milestones can be reasonably achieved. If the Company fails to diligently pursue issuance of the state recreational licenses at any time prior to the second anniversary, and the Company fails to cure such failures in accordance with the Merger Agreement, the Company will owe to Sellers a termination fee equal to 25% of the Merger Consideration Shares. The likelihood of achieving both milestones is uncertain at this time and, as such, the Company recorded the Merger Consideration Shares at par value. The acquisition was accounted for as an asset acquisition since the Surviving Entity did not meet the definition of a business in accordance with ASC 805, as it had no outputs and did not have a substantive process that could significantly contribute to the ability to create outputs. In accordance with ASC 805-50 and measurement of share-based payment in ASC 718, the acquisition should be measured on the date on which the acquirer obtains control of the acquiree. The date on which the acquirer obtains control of the acquiree generally is the date on which the acquirer legally transfers the consideration, acquires the assets, and assumes the liabilities of the acquiree. The Company obtained 100% ownership and control over the Merged Entity and the lease asset on 21 December 2022. The purchase price, as measured on 21 December 2022, was $170,000 which was included in the lease liability and right-of-use assets calculation for the lease acquired in the State of New Jersey (see Note 13). NMG IL 4, LLC – Asset Acquisition from a Related Party In 2019, the Company’s wholly owned subsidiary, DEP Nevada, Inc. (“DEP”), executed definitive agreements with NMG Illinois, LLC (“Management Company”), IL Resident, LLC (“IL Resident”), an entity which is controlled by our social equity partner, and other NMG entities in Illinois, NMG IL 1, LLC (“NMG IL 1”) and NMG IL 4, LLC (“NMG IL 4”), in connection with a proposed business combination (the “Transaction”). NMG IL 1 and NMG IL 4 were originally owned by Tall Bird, LLC (“Tall Bird”), a company owned by our social equity partner, and Big Stone, LLC (“Big Stone”), a company controlled by the Company’s Chief Operating Officer. The Transaction with NMG IL 4 expands our retail operation in the limited license jurisdiction and ownership has been transferred to DEP, however, the Company through DEP controls NMG IL 4 and is consolidating the financial information from NMG IL 4 from the opening day of the dispensary on April 25, 2023 as described in more detail below. a) DEP entered into a Convertible Credit Facility Agreement (the “Convertible Note”) with NMG IL 4 on December 26, 2019 to build-out the facility for up to $1,500,000 in lieu of converting into 99,900 membership units of NMG IL 4; b) DEP also entered into a Membership Interest Purchase Agreement (the “MIPA”) on December 26, 2019 with both Tall Bird and Big Stone to purchase the remaining 100 units for $10 per unit; c) Upon receipt of the Illinois license, NMG IL 4 entered into a management agreement with Management Company and would be paid a management fee equal to 30% of net profits; a) NMG IL 4 was granted the operational license on April 20, 2023; b) On April 25, 2023, DEP converted the Convertible Note for 99,900 units and purchased 100 units for $1,000 pursuant to the MIPA, after the opening of the Markham dispensary on or about April 25, 2023; c) Upon the conversion, DEP obtained 100% ownership (or 100,000 units) of NMG IL 4, subject to regulatory approval (pending); d) The Management Agreement has been dissolved concurrently with the conversion, in the meanwhile, the Company took control of operations of NMG IL 4. The acquisition of NMG IL 4 was accounted for as an asset acquisition with a related party since NMG IL 4 did not meet the definition of a business in accordance with ASC 805. The purchase price, as measured on 25 April 2023, was $995,035 in advances under the Convertible Note. The following table summarizes the assets acquired and the liabilities assumed: Assets acquired: Cash 100,707 Prepaid and deposits 70,230 Inventory 194,075 Property and equipment 918,492 Liabilities assumed: Trade payable and accrued liabilities (288,469 ) Net assets acquired $ 995,035 As the acquisition of NMG IL 4 was from a related party, the Company did not recognize any fair value increase in assets acquired or liabilities assumed, nor recognized any intangible assets. The excess of the amount paid over the fair value of the net assets acquired was included in Business Development expenses during the current period. |
Intangible Assets Net
Intangible Assets Net | 12 Months Ended |
Jul. 31, 2023 | |
Intangible Assets Net | |
Intangible Assets, Net | 10. Intangible Assets, Net As of 31 July 2023 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 370,000 - $ - $ 370,000 Licenses 4,683,508 10.0 (1,053,576 ) 3,629,932 Total intangible assets $ 5,053,508 $ (1,053,576 ) $ 3,999,932 As of 31 July 2022 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 425,000 - $ - $ 425,000 Licenses 11,193,508 10.0 (1,934,334 ) 9,259,174 Total intangible assets $ 11,618,508 $ (1,934,334 ) $ 9,684,174 Amortization expense for intangible assets was $1,021,260 and $266,753 for the year ended 31 July 2023 and 2022, respectively. During the year ended 31 July 2023, the Company recorded an impairment loss of $55,000 (2022 - $42,000) and $4,607,982 (2022 - $7,925,000) related to NMG’s and NMG LB’s brand and licenses, respectively. The expected amortization of the intangible assets, as of 31 July 2023, for each of the next five years and thereafter is as follows: Presented based on fiscal year 2024 $ 371,631 2025 370,616 2026 370,616 2027 370,616 2028 371,632 Thereafter 1,774,821 $ 3,629,932 |
Related Party Balances and Tran
Related Party Balances and Transactions | 12 Months Ended |
Jul. 31, 2023 | |
Related Party Balances and Transactions | |
Related Party Balances and Transactions | 11. Related Party Balances and Transactions In addition to those disclosed elsewhere in these consolidated financial statements, related party transactions paid/accrued for the year ended 31 July 2023 and 2022 are as follows: For the year ended 31 July 2023 For the year ended 31 July 2022 A company controlled by the President, Chief Executive Officer and a director Management fees $ 212,505 $ 284,533 A company controlled by the Chief Financial Officer and a director Management fees 81,614 134,693 A company controlled by the Corporate Secretary Management fees 56,647 87,748 $ 350,766 $ 506,974 On 25 April 2023, the Company granted an aggregate of 4,050,000 stock options (the “Options”) in accordance with the Company’s stock option plan at an exercise price of CAD$0.065 per share for a term of five years expiring on 25 April 2028 (Note 14). The Options are subject to vesting provisions such that 25% of the Options vest six (6) months from the date of grant, 25% of the Options vest twelve (12) months from the date of grant, 25% of the Options vest eighteen (18) months from the date of grant and 25% of the Options vest twenty-four (24) months from the date of grant. On 25 April 2023, the Company granted an aggregate of 5,323,000 stock options (the “Options”) in accordance with the Company’s stock option plan at an exercise price of CAD$0.065 per share for a term of five years expiring on 25 April 2028 (Note 14). The Options vest immediately. Amounts owing to related parties at 31 July 2023 and 2022 are as follows: a) As of 31 July 2023, the Company owed $61,777 (2022 - $102,480) to the Chief Executive Officer of the Company and a company controlled by him. b) As of 31 July 2023, the Company owed $31,704 (2022 - $31,704) to the Chief Operating Officer. c) As of 31 July 2023, the Company owed $Nil (2022 - $10,780) to the Chief Financial Officer of the Company and a company controlled by him. d) As of 31 July 2023, the Company owed $Nil (2022 - $18,898) to the Corporate Secretary of the Company and a company controlled by him. e) See also Note 9 for merger agreement with Crafted Plants NJ Corp. and Note 12 for convertible debentures financing with entities controlled by a new Company Director. f) See also Note 9 for the acquisition of NMG IL 4. g) The Company is committed to pay a commission fee of 2.5% of the transaction total to Bengal Impact Partners LLC, a company controlled by Josh Rosen, in connection with the disposition of NMG OH 1. The above amounts owing to related parties are unsecured, non-interest bearing and are due on demand. |
Loans Payable and Convertible D
Loans Payable and Convertible Debenture | 12 Months Ended |
Jul. 31, 2023 | |
Loans Payable and Convertible Debenture | |
Loans Payable and Convertible Debenture | 12. Loans Payable and Convertible Debenture As of 31 July 2023 and 2022, the following loans payable are outstanding: 31 July 2023 31 July 2022 FocusGrowth loan $ 6,666,667 $ 6,666,667 Long Beach loan 10,728 12,535 Canopy loan Secured promissory note 2,300,000 2,300,000 Unsecured loan balance 7,052 - CCG loan 148,221 - Total principal amount $ 9,132,668 $ 8,979,202 Debt discount (1,187,008 ) (1,573,031 ) Outstanding balance, net $ 7,945,660 $ 7,406,171 Current portion (166,001 ) (12,535 ) Long-term portion $ 7,779,659 $ 7,393,636 FocusGrowth loan On 19 July 2021, the Company entered into and closed a loan agreement (the “Loan Agreement”) with FG Agency Lending LLC (the “Agent”) and Bomind Holdings LLC (the “Lender”). Upon entering into the Loan Agreement, the Lender provided the initial term loan (the “Initial Term Loan”) in the face amount of $6,666,667 of which $6,000,000 was advanced to the Company with the 10% representing an origination discount as consideration for the use or forbearance of money. The Company may draw upon the remaining face amount of $4,444,444 (the “Delayed Draw Term Loan”) upon providing a 30-day request to the Agent by 1 December 2021, whereby $4,000,000 will be advanced to the Company after applying the 10% origination discount. The Initial Term Loan and the Delayed Draw Term Loan mature on 19 July 2025 and bear interest at a rate of 13% per annum payable on the first day of each month hereafter. Pursuant to the Loan Agreement, the Company issued an aggregate of 8,000,000 common stock purchase warrants (each, a “Warrant”) to the Agent of which (i) 4,800,000 Warrants will entitle the holder to acquire shares of common stock (each, a “Warrant Share”) at an exercise price of $0.40 per Warrant Share until July 19, 2025, and (ii) 3,200,000 Warrants was held in escrow to be released to the Agent at the time the Company draws on the Delayed Draw Term Loan, or cancelled if we do not draw on the Delayed Draw Term Loan, which will entitle the holder to acquire a Warrant Share at an exercise price of $0.45 per Warrant Share until July 19, 2025. The Company did not draw on the Delayed Draw Term Loan, and the warrants were cancelled. The Company also paid agent fees, legal fees and other fees in the amount of $175,758. The 4,800,000 Warrants had a relative fair value of $1,037,146 and when combined with the $175,758 in fees and the $666,667 origination discount, resulted in a debt discount of $1,883,901. The Initial Term Loan is secured by certain of the Company’s assets, equity interest in subsidiaries and various agreements, under the Security Agreement, the Pledge Agreement and the Omnibus Collateral Assignment. On 15 June 2022, the Company entered into a second amendment to the Loan Agreement (“Amendment No. 2 to Loan Agreement”) to extend the maturity date by one year to 19 July 2026. Additionally, Amendment No. 2 to Loan Agreement allows the outside date for the Company to draw on the delayed draw term loan of US$4.44 million to be extended from June 1, 2022 to March 31, 2023, whereby US$4 million in funds will be advanced to the Company. The ability of the Company to draw on the delayed draw term loan was subject to compliance with certain provisions in Loan Agreement including provision of a satisfactory budget approved at the sole discretion of the Lender. The Company did not draw or extend the Delayed Draw Term Loan and has expired. The Amendment No. 2 to Loan Agreement increases the interest rate on the advanced funds from 13% to 15% per annum, which additional 2% interest may be paid in kind, with the interest being payable on the first day of each month. Amendment No. 2 to Loan Agreement provides for an exit fee equal to 1.5% of the principal balance, which is due and payable upon any payment, in part or in full, of the initial term loan and the delayed draw term loan. As partial consideration for Amendment No. 2 to Loan Agreement, the Company has issued 1,000,000 common stock purchase warrants (each, a “Warrant”) to the Lender. Each Warrant entitles the holder to acquire one share of common stock (each, a “Warrant Share”) at an exercise price of US$0.16 per Warrant Share until June 14, 2027. The Amendment No. 2 to Loan Agreement was accounted for as a modification consistent with ASC 470-50, Debt Modification, where the lender fees, including 1,000,000 additional common stock purchase warrants valued at $79,585 and the exit fee of $100,000, are capitalized as additional debt discount and amortized as par to the effective yield. On December 12, 2022, the Company, the Guarantors (collectively, the “Loan Parties”) the Agent and the Lender entered into a Limited Waiver and Amendment to Loan Agreement (the “Limited Waiver and Amendment to Loan Agreement”) to deal with certain events of default that occurred under the Loan Agreement, as amended, with respect to (i) the Company’s failure to deliver to Agent the audited annual financial statements of the Company and its subsidiaries for the fiscal year ended July 31, 2022, on or before ninety (90) days after the end of such fiscal year in accordance with Section 7.2I of the Loan Agreement (the “First Specified Default”) and (ii) the Agent being informed that the Company anticipates that it will fail to deliver the quarterly financial statements of the Company and its subsidiaries for the fiscal quarter ending October 31, 2022, in form and substance acceptable to Agent, on or before forty-five (45) days after the end of such fiscal quarter, in accordance with Section 7.2(b) (the “Second Specified Default”, and together with the First Specified Default, the “Specified Defaults”). Pursuant to the Limited Waiver and Amendment to Loan Agreement, the Agent and the Lender each waive the Specified Defaults on a limited one-time basis subject to the terms and conditions thereof until (i) with respect to the First Specified Default, 5:00 PM EST on December 30, 2022, and (ii) with respect to the Second Specified Default, 5:00 PM EST on January 13, 2023 (the “Waiver Period”); provided that if the Loan Parties do not deliver each of the Amended Deliverables (as defined below) on or before expiration of their respective Waiver Period; the waiver shall no longer be of any effect, and the Lender shall be entitled to enforce all remedies set forth in the Loan Agreement as of the date each Specified Default first occurred. Subsequent to entering into the Limited Waiver and Amendment to Loan Agreement, the parties verbally agreed and confirmed via email on December 20, 2022, that Waiver Period for the First Specified Default shall be extended from December 30, 2022 to January 17, 2023, and the Waiver Period for the Second Specified Default shall be extended from January 13, 2023 to January 27, 2023; and that the corresponding amendments shall be made to sections 7.2(b) and 7.2(c) of the Loan Agreement as set forth above. During the year ended 31 July 2023, the Company recorded $399,637 related to the amortization of debt discount and $1,022,614 related to the interest expense. Long Beach loan The loan payable at 31 July 2023 in the amount of $10,728 (2022 - $12,535) assumed from NMG LB is unsecured, non-interest bearing and has no set terms of repayment. Canopy loan On 30 November 2021, the Company completed PA #1 related to the Company’s acquisition of initial 80% interest in Canopy (Note 9). In connection with PA #1, DEP entered into secured promissory note (the “Promissory Note”) promising to pay $2,300,000 to the Sellers bearing interest at a rate of 10% per annum compounded annually and having a maturity date of 30 November 2026. The Promissory Note was delivered as partial consideration for DEP’s agreement to purchase 80% of the issued and outstanding membership interests (the “Purchased Interests) of Canopy from the Sellers. The loan payable at 31 July 2023 in the amount of $7,052 (2022 - $nil) assumed from Canopy is unsecured, non-interest bearing and has no set terms of repayment. CCG loan The Company received operating loans from CCG that are non-interest bearing, unsecured and due on demand. During the year ended 31 July 2023, the Company received $148,221 (2022 - $Nil). At 31 July 2023, the amount payable to CCG was $148,221 (2022 – $Nil). See also Note 6. Convertible Debenture Financing – Related Parties As of 31 July 2023 and 2022, the following convertible debentures are outstanding: 31 July 2023 31 July 2022 BAM I, A Series of Bengal Catalyst Fund SPV, LP (related party – Note 9) $ 2,750,000 $ - Mindset Value Fund LP 150,000 - Mindset Value Wellness Fund LP 100,000 - Total principal amount $ 3,000,000 $ - Debt discount (519,478 ) - Outstanding balance, net $ 2,480,522 $ - On December 19, 2022, the Company entered into Securities Purchase Agreements (“SPAs”) with each of BAM I, A Series of Bengal Catalyst Fund SPV, LP, a Delaware limited partnership, an entity which is controlled by a Company Director, Mindset Value Fund LP, a Delaware limited partnership, and Mindset Value Wellness Fund LP, a Delaware limited partnership (collectively, the “Investors”) pursuant to which the Company issued to the Investors unsecured five-year convertible debentures in the aggregate principal amount of US$3,000,000 (the “Debentures”) bearing interest at 8% per annum, compounded annually, and common stock purchase warrants (the “Warrants”) to acquire 15,000,000 shares of common stock of the Company (each, a “Warrant Share”). The proceeds from the sale of the Debentures and the Warrants will be used for business development purposes. In addition, pursuant to the SPAs, following the closing and until the later of (a) the repayment or conversion of the Debentures, and (b) Bengal Impact Partners, LLC (“Bengal Capital”) (or any of its affiliates) ceasing to own at least 10% of the issued and outstanding shares of common stock on an as-converted basis in the aggregate, Bengal Capital shall be entitled to nominate one (1) director to the Company’s Board and one (1) Board observer, provided that the nominee director must meet the requirements of applicable corporate, securities and other applicable laws, and the policies of the Canadian Securities Exchange. Joshua Rosen was appointed to the Board of Directors on 1 February 2023. Bengal Capital and CraftedPlants NJ Corp. were both owned and managed by the principals of the Bengal Capital. As Joshua Rosen is a managing principal of the Bengal Capital Group, he was involved in both transactions of the convertible note investment and the merger acquisition of Crafted Plants NJ. The Debentures have a maturity date of December 19, 2027 (the “Maturity Date”) and the accrued interest shall be payable on the Maturity Date. The Investors have the right at any time prior to the Maturity Date, to convert all or any portion of the principal amount and/or any interest amount, into shares of common stock of the Company at US$0.10 per share, subject to customary adjustments, and subject to a beneficial ownership limitation by each Investor and their respective affiliates of 9.99% of the outstanding shares of common stock of the Company, provided, however, that the beneficial ownership limitation on conversion may be waived by the Investor upon providing not less than 61 days’ prior notice to the Company. The Warrants will entitle the holders to acquire Warrant Shares until December 19, 2026, at an exercise price of US$0.10 per Warrant Share, subject to customary adjustments. The Warrants can be exercised on a cash basis or on a cashless (net exercise) basis. The Warrants contain the same beneficial ownership limitation as the Debentures. During the year ended 31 July 2023, the Company recorded the interest expense of $159,476 related to the Debentures. The loan balance as at 31 July 2023 was $3,000,000, net of remaining debt discount of $519,478 (2022 - $nil). |
Operating Leases
Operating Leases | 12 Months Ended |
Jul. 31, 2023 | |
Operating Leases | |
Operating Leases | 13. Operating Leases a) On 10 November 2017, Nevada Medical Group, LLC entered a ten-year lease agreement with Resort Holdings 5, LLC, a Nevada limited liability company, for the property located at 3375 Pepper Lane, Las Vegas, NV, containing approximately 18,000 square feet. We have four options to extend the lease agreement and each option is for five years. In July 2018, Resort Holdings 5, LLC, the landlord, sold the property to a third party and assigned the lease to Minor Street Properties, LLC. All lease terms remained the same. On 9 May 2022, we amended the lease agreement which exercised our first option to extend the lease for an additional five years with rent during the option term subject to a 3% increase on each anniversary date of the lease. The monthly rent was $13,663 + common area expenses and increased to $13,936 + common area expenses on 1 December 2022. Currently, the guaranteed minimum monthly rent is subject to a 2% increase on each anniversary date of the lease. b) On 7 May 2019, Nevada Medical Group, LLC entered into a five-year lease agreement with Haigaz and Nora Atamian, commercial property owners, for the property located at 6420 Sunset Corporate Drive, Las Vegas, NV, containing approximately 7,700 square feet. We have two options to extend the lease for an additional three-year term and an option to purchase the property at any point during the initial term. The monthly rent was $6,478 + common area expenses, increased to $6,780 + common area expenses on 1 May 2022 and increased to $7,081 + common area expenses on 1 May 2023. The guaranteed minimum monthly rent is subject to a $0.03 per square foot, per month, increase on each anniversary date of the lease for years one through three of the term and $0.04 per square foot, per month, increase on each anniversary date of the lease for years four through five of the term. c) On 1 December 2018, SGSD, LLC entered into a five-year lease agreement with Green Road, LLC, a California limited liability company, for the property located at 7625 Carroll Road, San Diego, California, containing approximately 4,600 square feet. On June 13, 2019, SGSD, LLC assigned the lease to NMG San Diego, LLC. Under the terms of the assignment and first amendment to the original lease agreement dated 13 June 2019, we have three options to extend the lease and each option is for five years. The monthly base rent was $15,913 + common area expenses, increased to $16,390 + common area expenses on 1 January 2021 and increased to $16,883 on 1 January 2022. The guaranteed monthly rent is subject to a 6% increase on each anniversary date of the lease, based on increases in the Consumer Price Index for San Diego County. The lease contains a sale bonus provision of $1,000,000 or 10% of the purchase price of the entire business, whichever is greater, in the event of sale or assignment of the lease. d) On 2 August 2018, NMG Ohio, LLC entered into a three-year lease agreement with MMCA Development, LLC, an Ohio limited liability company, for the property located at 709 Sugar Lane, Elyria, Ohio 44035, containing approximately 4,100 square feet. The Company has three options to extend the lease and each option is for three years. On 14 August 2020, NMG Ohio, LLC assigned the lease agreement to NMG OH 1, LLC. On 11 May 2021, we exercised our option to extend the lease agreement for an additional three years. The rent was $4,000 per month and increased to $4,200 per month on 1 July 2021. The minimum monthly rent is subject to a 5% increase for each option period. e) On 10 January 2017, SJK Services, LLC entered into a five-year lease agreement with Meng Lin Zhang, a commercial property owner, for the property located at 3411 E. Anaheim St., Long Beach, California, containing approximately 1,856 square feet. On 7 September 2018, SJK Services, LLC amended its lease agreement with Meng Lin Zhang. On 14 December 2018, SJK Services, LLC assigned the amended lease agreement to The Airport Collective, Inc., a California corporation. On 8 March 2019, The Airport Collective, Inc. assigned the amended lease agreement to NMG Long Beach, LLC. On 14 June 2021, we exercised our option to extend the lease agreement for one additional term of five years. On 1 March 2022, we amended the lease agreement to include two additional options to extend the lease agreement for five years each and expanded the lease agreement to include 3413 E. Anaheim St., Long Beach, California, containing approximately 816 square feet. The guaranteed minimum monthly base rent was $7,316 + common area expenses for unit 3411, increased to $7,682 + common area expenses in January 2022, increased to $8,067 + common area expenses in January 2023, and is subject to a 5% increase on each anniversary date of the lease. The guaranteed monthly base rent for unit 3413 was $1,632 + common area expenses, increased to $1,681 + common area expenses on 1 April 2023 and is subject to a 3% increase on each anniversary date of the lease agreement. f) On 1 October 2019, NMG Ohio, LLC entered into a three-year lease agreement with MMCA Development, LLC, an Ohio limited liability company, for the property located at 719 Sugar Lane, Elyria, Ohio 44035, containing approximately 4,000 square feet. We have three options to extend the lease agreement for an additional three-year term. The guaranteed minimum monthly rent is subject to 5% increase for each option period. On 1 September 2021, the lease agreement was assigned to NMG OH P1, LLC with the same terms. On 18 October 2022, NMG OH P1, LLC extended the lease agreement with MMCA Development, LLC for one additional term of three years. The base rent is $4,200 plus common area expenses. g) On 23 April 2021, NMG MI 1, Inc. entered into a five-year lease agreement with Kendal Properties, LLC, a Michigan limited liability company, for the property located at 885 E. Apple Ave., Muskegon, Michigan 49442, containing approximately 2,500 square feet. The base rent was $5,000 during the operational period, which began after the rent abatement and reduced rent periods, increased to $5,100 on 1 May 2022 and increased to $5,202 on 1 May 2023. The lease agreement includes 2% annual base rent increases and three options to extend for five-years each. Upon NMG MI 1 receiving one or more licenses, NMG MI 1 agrees to cause the Company to issue common shares having a value of up to $150,000 to Kendal, with portions of the common shares to be issued upon the achievement of certain milestones as follows: i. 25% of the common shares to be issued within 30 days following NMG MI 1’s receipt of a local commercial medical marihuana retail license from the city of Muskegon, MI and a state commercial medical marihuana retail license from the state of Michigan; ii. 25% of the common shares to be issued within 30 days following NMG MI 1 passing final inspections at the Leased premises regarding the commercial medical marihuana retail license and receiving its local operating permit allowing NMG MI 1 to begin medical marihuana operations at the premises; iii. 25% of the common shares to be issued within 30 days following NMG MI 1’s receipt of a local commercial adult-use marihuana retail license from the city of Muskegon, MI and a state commercial adult-use marihuana retail license from the state of Michigan; iv. 25% of the common shares to be issued within 30 days following NMG MI 1 passing final inspections at the Leased premises regarding the commercial adult-use marihuana retail license and receiving its local operating permit allowing NMG MI 1 to begin adult-use marihuana operations at the premises; During the year ended 31 July 2022, the Company accrued $151,480 as all milestones were met and later issued the necessary common shares to settle $75,000 of this liability (Note 14). On 3 March 2022, the Company’s subsidiary, NMG MI 1, Inc. entered into an Amendment No. 1 to Lease Agreement with Kendal Properties, LLC with respect to the premises located at 885 E. Apple Ave., Muskegon, Michigan, whereby the parties amended the original Lease Agreement to provide that two of the milestone payments that were to be made in the form of the Company’s shares are to now be made in the form of cash. At 31 July 2022, the accrued liabilities for the above milestones are fully settled. Based on the fact that the NMG MI 1 was disposed of at a nominal amount in accordance with the Stock Purchase Agreement (Note 19), the fair value of the asset group of NMG MI 1 was determined to be $nil as at April 30, 2023. As a result, the Company impaired the right-of-use asset related to NMG MI 1 during the period ended April 30, 2023. The lease liability at 31 July 2023 related to NMG MI 1 was $333,720. h) On 10 February 2021, NMG MI C1, Inc. entered into a five-year lease agreement with 254 River Street, LLC, a Michigan limited liability company, for the property located at 254 River St., Manistee, Michigan 49660, containing approximately 30,000 square feet. The base rent is $22,500 during the operational period, beginning after the rent abatement and reduced rent periods. The lease agreement includes 2% annual base rent increases and three options to extend for five-years each. The license(s) would allow NMG MI C1 to operate a cultivation facility for adult-use and/or medical marihuana and all activities permissible under the Michigan and Manistee Marihuana Laws. Upon NMG MI C1 receiving one or more Licenses, NMG MI C1 agrees to cause the Company to issue common shares having a value of up to $600,000 to River Street, with portions of the Common Shares to be issued upon the achievement of certain milestones as follows: i. US$200,000 of common shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana cultivation licenses; ii. US$200,000 of common shares to be issued within 30 days of passing final inspections at the premises with respect to cultivation and receiving local operating permit to begin commercial marihuana cultivation operations at the premises; iii. US$100,000 of common shares to be issued within 30 days of NMG MI C1 receiving local and state commercial marihuana retail licenses; and iv. US$100,000 of common shares to be issued within 30 days of passing final inspections at the premises with respect to retail operations and receiving local operating permit to begin commercial marihuana retail operations at the premises. On 21 September 2021, the Company issued the necessary common shares to settle milestone (i) above (Note 14). During the year ended 31 July 2022, the Company accrued an additional $231,374 and were included in the related operating lease liability for milestone (ii) above. Milestones (iii) and (iv) have not yet been achieved as of 31 July 2023. At 31 July 2022, in order to better utilize its resources, it was deemed unlikely that the Company will continue to pursue the opportunity for a cultivation facility in Michigan. As a result, the Company impaired the right-of-use asset related to this lease during the year ended 31 July 2022. The lease liability at 31 July 2023 related to NMG MI C1 was $1,437,086. i) On 10 February 2021, NMG MI P1, Inc. entered into a five-year lease agreement with 254 River Street, LLC, a Michigan limited liability company, for the property located at 254 River St., Manistee, Michigan 49660, containing approximately 30,000 square feet. The base rent is $7,500 during the operational period, beginning after the rent abatement and reduced rent periods. The lease agreement includes 2% annual base rent increases and three options to extend for five-years each. The license(s) would allow NMG MI P1 to operate a production facility for adult-use and/or medical marihuana and all activities permissible under the Michigan and Manistee Marihuana Laws. Upon NMG MI P1 receiving one or more Licenses, NMG MI P1 agrees to cause the Company to issue common shares having a value of up to $400,000 to River Street, with portions of the Common Shares to be issued upon the achievement of certain milestones as follows: i. US$200,000 of common shares to be issued within 30 days of NMG MI P1 receiving local and state commercial marihuana processing licenses; and ii. US$200,000 of common shares to be issued within 30 days of passing final inspections at the premises with respect to processing and receiving local operating permit to begin commercial marihuana processing operations at the premises. During the year ended 31 July 2022, a total deposit $470,546 for prior year shares were reclassified and incorporated into the right-of-use asset and lease liabilities related to the Company’s leases for the River Street. On 21 September 2021, the Company issued the necessary common shares to settle milestone (i) above (Note 14). During the year ended 31 July 2022, the Company accrued an additional $239,173 and were included in the related operating lease liability for milestone (ii) above. At 31 July 2022, in order to better utilize its resources, it was deemed unlikely that the Company will continue to pursue the opportunity for a production facility in Michigan. As a result, the Company impaired the right-of-use asset related to this lease during the year ended 31 July 2022. The lease liability at 31 July 2023 related to NMG MI P1 was $479,029. The value of the common shares will be calculated based on the lesser of: (1) the closing market price on the respective milestone achievement date and (2) a ten percent discount to the twenty-day volume weighted average price for the twenty days immediately prior to the respective milestone achievement date(s). Leases for 254 River St., Manistee, Michigan 49660 and 885 E. Apple Ave., Muskegon, Michigan 49442 were subject to the Company subsidiaries receiving approval by the State of Michigan and could be cancelled by the Company if licences were not awarded. The licenses for NMG MI P1 and NMG MI C1 were issued on 19 July 2021 and license for NMG MI 1 was issued on 3 August 2021. j) On 1 July 2021, the Company’s subsidiary Canopy Monterey Bay, LLC assumed and entered into a three-and-a-half-year lease agreement for the property located at 1900 Fremont Blvd., Seaside, California 93955. On 1 December 2021, Canopy Monterey Bay, LLC entered into a second amendment that includes three options to extend the lease agreement for five years each with 3% annual base rent increases. The base rent is now $9,000 per month until June 2023. In March 2023, the Company and the landlord agreed to extend the lease for until 30 June 2028. Canopy Monterey Bay, LLC agreed to pay the landlord a maintenance fee equal to 1.5% of gross sales each month. k) On 7 April 2022, DEP Nevada, Inc. entered into a three-year lease agreement with 2625 GV, LLC, a Nevada limited liability company, for the property located at 2625 N. Green Valley Pkwy., Ste 150, Henderson, Nevada 89014, containing approximately 5,059 square feet. The base rent was $4,482 per month plus common area expenses and increased to $4,662 per month plus common area expenses on 1 June 2023. The lease agreement includes 4% annual base rent increases and two options to extend for three years each. l) On 4 December 2020, NMG CA P1, LLC entered into a five-year lease agreement with Cat City 2, LLC, a California limited liability company, for the property located at 68945 Perez Rd., Suite 1, Cathedral City, California 92234, containing approximately 5,840 square feet. The lease agreement includes 3% annual base rent increases and two options to extend for five-years each. We amended the lease agreement on 27 January 2022, which extended the term to 31 December 2026 and rent commencement date. The base rent is $6,028 plus common area expenses for the first six months, increases to $9,590 plus common area expenses on the seventh month and increases to $9,878 plus common area expenses on 1 March 2023. m) On 1 December 2020, NMG CA C1, LLC entered into a five-year lease agreement with Cat City 2, LLC, a California limited liability company, for the property located at 68945 Perez Rd., Suite 2,3&4, Cathedral City, California 92234, containing approximately 13,024 square feet. The lease agreement includes a rent abatement period, 3% annual base rent increases and two options to extend for five-years each. We amended the lease agreement on 2 February 2022, which extended the term to 31 December 2026. The base rent increased to $22,790 plus common area expenses effective January 1, 2023 and increases to $23,474 plus common area expenses effective March 1, 2023. n) On 15 February 2022, CraftedPlants NJ Corp. (“Tenant”) entered into a lease agreement (the “Lease”) with Simone Investment Group, LLC, a New Jersey limited liability company, for the property located at 3191 U.S. Route 1, Lawrenceville, New Jersey 08648, containing approximately 6,923 square feet. The term of this Lease consists of Phase I commencing on 15 February 2022 (the “Lease Commencement Date”) and ending on the earlier of (i) twelve months from the Lease Commencement Date, (ii) upon issuance to Tenant of the Class 5 Cannabis Retail License by the Commission plus thirty days, or (iii) the date when the Tenant opens for business; and Phase II of ten years from the earlier of (i) the date when the Tenant opens for business, (ii) twelve months from 15 February 2022, or (iii) thirty days after the issuance to Tenant of the Class 5 Cannabis Retail License by the Commission. Tenant has four options to extend the lease and each option is for five years. On 21 December 2022, the Company acquired the rights to the lease agreement from the merger with CraftedPlants NJ Corp. for consideration of $170,000 (Note 9). The rent for Phase I was $10,000 per month for the first eight months and increased to $14,000 per month on the nineth month. The rent for Phase II was $25,146 annually for the first five years and increased to $29,583 annually on the sixth year. o) On 4 January 2022, NMG IL 4, LLC entered into a ten-year lease agreement with CB Chicago Partners, Ltd., a Texas limited partnership, for the property located at 2941 W. 159 th th During the year ended 31 July 2023, the Company recorded a total lease expense of $662,572 related to the amortization of right-of-use assets, of which $1,283,987 was included in Operating Expenses and $259,387 was included in Cost of Sales. Supplemental cash flow information related to leases was as follows: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,582,411 Weighted-average remaining lease term – operating leases 7.03 years Weighted-average discount rate – operating leases 12 % The discount rate of 12% was determined by the Company as the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Maturities of lease liabilities were as follows: Year Ending 31 July Operating Leases 2024 $ 2,114,388 2025 2,026,131 2026 1,978,981 2027 1,677,468 2028 and thereafter 5,700,655 Total lease payments $ 13,497,623 Less imputed interest (4,538,918 ) Total $ 8,958,705 Less current portion (1,099,888 ) Long term portion $ 7,858,817 At 31 July 2023 and 2022, the right-of-use assets and the lease liabilities related to NMG OH 1 and NMG OH P1 have been reclassified to assets held for sale and liabilities related to assets held for sale as follows: 31 July 2023 31 July 2022 NMG OH 1 – right-of-use assets $ 158,336 $ 188,165 NMG OH P1 – right-of-use assets $ 198,412 $ 223,527 NMG OH 1 – lease liabilities $ 162,552 $ 191,529 NMG OH P1 – lease liabilities $ 202,618 $ 226,303 The lease liabilities related to NMG MI 1 have been deconsolidated as of the date of the disposition. |
Capital Stock
Capital Stock | 12 Months Ended |
Jul. 31, 2023 | |
Capital Stock | |
Capital Stock | 14. Capital Stock The Company’s authorized share capital comprises 900,000,000 Common Shares, with a $0.0001 par value per share. On 21 September 2021, the Company issued 238,929 common shares to one entity based on the terms and conditions of the certain lease agreement for the Muskegon, Michigan premises and issued an aggregate of 1,304,601 common shares to another entity based on the terms and conditions of the two lease agreements for the Manistee, Michigan premises (Notes 13 and 16). Pursuant to the ShowGrow Long Beach Purchase Agreement, the Company issued 2,681,006 common shares in escrow. The share consideration remains subject to reduction with reference to the liabilities of the business that will be outstanding on the closing date, which is expected to occur in the near future (Note 17). Pursuant to the PA #2 for the acquisition of Canopy’s membership interest, the Company issued 2,728,156 common shares on 3 December 2021 in escrow (Note 9). On 15 July 2022, the Company issued 319,149 common shares to one entity based on the terms and conditions of the certain lease agreement for the Muskegon, Michigan premises. Pursuant to the closing of MIPA #1, as amended, and MIPA #2, as amended, for the acquisition of Canopy’s membership interest, the Company issued an aggregate of 16,301,694 shares of common stock on 7 December 2022, of which 2,238,806 are being held in escrow ending the results of a working capital adjustment in accordance with MIPA #1 and MIPA #2 (Note 9). Pursuant to the terms of the Merger Agreement with CraftedPlants, NJ, the Company issued an aggregate of 16,666,667 common shares on 21 December 2022 in escrow (Note 9). Stock options The Company previously approved an incentive stock option plan, pursuant to which the Company may grant stock options up to an aggregate of 10% of the issued and outstanding common shares in the capital of the Company from time to time. Number of options Weighted average exercise price Weighted average contractual term remaining (in years) Aggregate intrinsic value Outstanding at 31 July 2021 9,855,000 CAD$0.71 2.76 CAD$ - Granted 848,000 CAD$0.37 CAD$ - Cancelled (1,250,000 ) CAD$0.70 CAD$ - Outstanding at 31 July 2022 9,453,000 CAD$0.67 2.11 CAD$ - Granted 9,773,000 CAD$0.07 CAD$ - Expired (2,075,000 ) CAD$0.64 CAD$ - Outstanding at 31 July 2023 17,151,000 CAD$0.33 3.16 CAD$ - Vested and fully exercisable at 31 July 2023 12,989,000 CAD$0.41 2.69 CAD$ - As of 31 July 2023, the following stock options are outstanding: Number of options outstanding Number of options exercisable Exercise price Expiry dates 775,000 775,000 CAD$0.57 10 December 2023 1,600,000 1,600,000 CAD$0.88 21 August 2024 250,000 250,000 CAD$0.93 1 October 2024 200,000 200,000 CAD$0.88 23 January 2025 250,000 250,000 CAD$0.405 1 March 2025 1,375,000 1,375,000 CAD$0.67 30 April 2025 350,000 350,000 CAD$0.88 21 August 2024 150,000 150,000 CAD$0.61 10 December 2023 80,000 80,000 CAD$0.57 10 December 2023 1,250,000 1,250,000 CAD$0.68 6 March 2026 250,000 250,000 CAD$0.65 5 April 2024 448,000 336,000 CAD$0.44 30 November 2026 200,000 200,000 CAD$0.44 30 November 2024 200,000 200,000 CAD$0.15 8 July 2027 4,050,000 - CAD$0.065 25 April 2028 5,723,000 5,723,000 CAD$0.065 25 April 2028 17,151,000 12,989,000 On 25 April 2023, the Company granted 4,050,000 stock options to certain directors, officers, employees and consultants of the Company with an exercise price of CAD$0.065 per share expiring on 25 April 2028. These stock options vest equally every 6 months for a period of 24 months. On 25 April 2023, the Company granted 5,723,000 stock options to certain directors, officers, employees and consultants of the Company with an exercise price of CAD$0.065 per share expiring on 25 April 2028. These stock options vest immediately. Total fair value of the stock options granted during the year ended 31 July 2023 was calculated to be $395,526 using the Black-Scholes Option Pricing Model using the following weighted average assumptions: Expected life of the options 2.76 years Expected volatility 103 % Expected dividend yield Nil Risk-free interest rate 3.27 % The Company recorded total stock-based compensation expense of $270,693 (2022 - $435,266) for the year ended 31 July 2023 and 2022, respectively, in connection with prior issuances of options to purchase common stock. Stock-based compensation expense is included in general and administrative expenses on the accompanying statements of operations. Share Purchase Warrants Number of warrants Weighted average exercise price Outstanding at 31 July 2021 17,215,284 CAD$1.21 Issued 1,000,000 USD$0.16 Outstanding at 31 July 2022 18,215,284 CAD$1.16 Issued 15,000,000 USD$0.10 Expired (12,415,284 ) CAD$1.49 Outstanding at 31 July 2023 20,800,000 CAD$0.23 The Company had 3,200,000 warrants issued to the Agent pursuant to the Loan Agreement entitling the holder to acquire one share of common stock at an exercise price of US$0.45 per share until July 19, 2025. These warrants were held in escrow to be released to the Agent if we draw on the Delayed Draw Term Loan by March 31, 2023, or cancelled if we do not draw on the Delayed Draw Term Loan. The Company did not draw on the Delayed Draw Term Loan, and the warrants were cancelled. During the year ended 31 July 2023, the Company issued 15,000,000 warrants in connection with the issuance of convertible debentures pursuant to SPAs (Note 12). The Warrants will entitle the holders to acquire Warrant Shares until December 19, 2026, at an exercise price of US$0.10 per Warrant Share, subject to customary adjustments. The Warrants can be exercised on a cash basis or on a cashless (net exercise) basis. The Debentures was accounted for as a liability in its entirety equal to the proceeds received from issuance, net of the fair value of the 15,000,000 Warrants valued at $592,159 using the Black Scholes Option Pricing Model using the following assumptions, which was recorded as a debt discount: Expected life of the options 4 years Expected volatility 107 % Expected dividend yield 0 % Risk-free interest rate 3.03 % As of 31 July 2023, the following warrants are outstanding: Number of warrants outstanding and exercisable Exercise price Expiry dates 4,800,000 USD$0.40 19 July 2025 15,000,000 USD$0.10 19 December 2026 1,000,000 USD$0.16 14 June 2027 20,800,000 CAD$0.23 As of 31 July 2022, the following warrants are outstanding: Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$1.50 17 May 2023 635,150 CAD$1.25 16 May 2023 4,800,000 USD$0.40 19 July 2025 1,000,000 USD$0.16 14 June 2027 18,215,284 CAD$1.16 |
Segmented Information and Major
Segmented Information and Major Customers | 12 Months Ended |
Jul. 31, 2023 | |
Segmented Information and Major Customers | |
Segmented Information and Major Customers | 15. Segment Information and Major Customers In its operation of the business, management, including our chief operating decision marker, who is also our Chief Executive Officer, reviews certain financial information, including segmented internal profit and loss statements prepared on a basis not consistent with GAAP. During the periods presented, the Company reported its financial performance based on the following segments: · Wholesale; · Retail; and · All others Revenue and costs are generally directly attributed to our segments. However, due to the integrated structure of our business, certain costs incurred by one segment may benefit other segments. In addition, certain costs incurred at a corporate level are not allocated to our segments. Segment revenue and net loss were as follows during the year ended 31 July 2023: 31 July 2023 Revenue Wholesale $ 5,070,441 Retail 17,749,542 Total $ 22,819,983 Net loss before taxes Wholesale $ (5,520,602 ) Retail (5,321,539 ) All others (7,312,063 ) Total $ (18,154,204 ) During the year ended 31 July 2023, the Company had no major customer over 10% of its revenues. |
Supplemental Disclosures with R
Supplemental Disclosures with Respect to Cash Flows | 12 Months Ended |
Jul. 31, 2023 | |
Supplemental Disclosures with Respect to Cash Flows | |
Supplemental Disclosures with Respect to Cash Flows | 16. Supplemental Disclosures with Respect to Cash Flows Year Ended 31 July 2023 2022 Cash paid during the period for interest $ 1,037,208 $ 876,364 Cash paid during the period for income taxes $ 25,663 $ 3,436,572 Pursuant to certain licensing milestones being achieved under a lease agreement for a premises in Muskegon, Michigan and certain licensing and operational milestones being achieved under two lease agreements for a premises in Manistee, Michigan, on 21 September 2021, the Company issued 238,929 shares of common stock to one entity based on the terms and conditions of the certain lease agreement for the Muskegon, Michigan premises and issued an aggregate of 1,304,601 shares of common stock to another entity based on the terms and conditions of the two lease agreements for the Manistee, Michigan premises (Notes 13 and 14). On the assumption of a lease in California for NMG CA C1, a lease in Illinois for NMG IL 4, a lease in New Jersey, and an extension of a lease in California for Canopy, the Company recognized right-of-use assets, and a corresponding increase in lease liability, in an aggregate amount of $4,329,416 which represented the present value of future lease payments using a discount rate of 12% per annum. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Jul. 31, 2023 | |
Commitments and Contingencies | |
Commitments and Contingencies | 17. Commitments and Contingencies From time to time, the Company may be subject to various legal proceedings in the ordinary course of its business. The Company intends to take appropriate action with respect to any such legal actions, including by defending itself against such legal claims as necessary. Acquisition of Long Beach On 3 July 2019, the Company entered into various agreements with GLDH and other third parties to acquire 100% ownership interest in GLDH’s Long Beach, California dispensary ("ShowGrow Long Beach"). The purchase price was $6,700,000, of which $1,500,000 was paid in common shares of the Company at a price of CAD$0.7439 per common share to a maximum of 2,681,006 common shares (the “Share Payment”) upon NMG LB receiving the transfer of all licenses, permits and BCC authorizations for NMG LB to conduct medical and adult-use commercial cannabis retail operations. The 2,681,006 common shares were issued on 12 August 2019. The Share Payment is subject to reduction with reference to the liabilities of the business that will be outstanding on the closing date, which is expected to occur in the near future. The Share Payment reduction is pending and, as a result, the related shares have not been released from escrow. Any final settlement that is different than liabilities' balances currently recorded will be allocated to other income or expense. Acquisition of Assets – Crafted Plants NJ On 21 December 2022, in conjunction with the Crafted Plant NJ asset acquisition, the Company issued 16,666,667 shares of its common stock, which will be held in escrow and will not be released to the Sellers until the Surviving Entity achieves certain milestones (Note 9). Since no cannabis sales have commenced, the $50,000 liability for consultant is not payable. The Company entered into a three-year strategic advisory services agreement with Bengal Capital dated 5 January 2023 (“Bengal Advisory Agreement”). The Company shall pay Bengal Capital $240,000 on each anniversary, of which $60,000 is to be paid in cash and $180,000 is to be paid in cash, common stock, or warrants to purchase shares of the Company’s common stock, in such proportions as are determined by the Company. The Company has accrued $140,000 under this agreement as of July 31, 2023. In addition, if the Company successfully obtains a cultivation license in New Jersey during the term of the Bengal Advisory Agreement, the Company will owe a fee of $1,000,000, which will be payable in the form of the Company’s common stock or a warrant to purchase shares of the Company’s common stock, in either case as requested by Bengal Capital. As of July 31, 2023, no license has been obtained and therefore the related fee has not been paid or accrued. Acquisition of Canopy At 31 July 2023, the Company had $100,000 in consulting fee payable to the sellers of Canopy (Note 9), related to the common shares that are to be issued to the Canopy sellers 18 months after the First Amendment in June 2022, that was not included in the purchase consideration and is included in accrued liabilities. As part of the Canopy acquisition agreements PA #1 and PA #2 on November 29, 2021, a Letter of Intent (“LOI”) was executed to engage the Sellers, Jayme Rivard and Cary Stiebel, as business consultants at a rate of $5,000 per month each, for 12 months beginning December 1, 2021. Subsequently, this LOI was amended on June 2, 2022 to extend the agreement until December 31, 2024 and for the Company to issue 100,000 stock options to purchase 100,000 shares of the Company 's common stock to Consultant, Mr. Stiebel, and 100,000 stock options to purchase 100,000 shares of the Company's common stock to Consultant, Jayme Rivard (collectively, the "Stock Options"). The exercise price for the Stock Options shall not be lower than the greater of the closing market price of the Company's shares on (a) the trading day prior to the date of grant of the Stock Options, and (b) the date of grant of the Stock Options and will have an expiry date of five (5) years from the date of grant. Any delays by any of the Sellers (as defined in PA # 1) in providing requested materials, escrow instructions or otherwise failing to cooperate with Buyer will extend the Closing Deadline by an amount corresponding to the length of delay caused by Sellers. As of the date of these financial statements, the Stock Options have not been granted. Further, this LOI was amended again on August 5, 2022 to defer all payments for consulting services from 1 August 2022 to 1 August 2023, in lieu of potential unknown working capital liabilities. Acquisition of Assts – Illinois On 17 January 2023, the Company entered into an agreement with John Kim, our consultant in the State of Illinois for a two-year services related to licensing process for a total payment of $86,500 payable in tranches until 10 June 2023, as well as $15,000 per month to three designated individuals for two (2) years ending on 31 December 2024, and $5,000 per month to one additional individual for six (6) months ending 30 June 2023 for an aggregate total of $476,500. On 10 May 2023, the Company entered into a Settlement and Release Agreement with John Kim to revise and increase the payments for services related to licensing process as described in the agreement that the Company entered into on 17 January 2023. Effective 10 May 2023, the revised committed payments total $733,150 as follows: a) $30,000 due 10 May 2023, $10,000 payable in each month of June, September, November 2023, and $15,000 each month for the period from January 2024 to February 2025, to John Kim; b) $7,500 per month to John Kim for May and June 2023, and $5,000 per month for remaining months until 31 December 2024; c) $5,000 or $5,833 per month to three designated individuals until 31 December 2024, except for certain months with variable payments ranging from $7,500 to $15,833. As of July 31, 2023, the Company has paid $114,816 under this agreement, leaving $618,334 to be earned subsequent to year-end. |
Other Agreements
Other Agreements | 12 Months Ended |
Jul. 31, 2023 | |
Other Agreements | |
Other Agreements | 18. Other Agreements On 6 August 2021, the Company entered into management agreements with each of NMG IL 1, LLC (“NMG IL 1”) and NMG IL 4, LLC (“NMG IL 4”) along with an option to indirectly acquire all of the membership interests in each of NMG IL 1 and NMG IL 4 pursuant to a convertible credit facility between our subsidiary, DEP and each of NMG IL 1 and NMG IL 4, and membership interest purchase agreements between DEP and the members of NMG IL 1 and NMG IL 4, subject to obtaining all required local and state regulatory authorization. Each of NMG IL 1 and NMG IL 4 have been identified in the Illinois Department of Financial and Professional Regulation (IDFPR) results of the Social Equity Justice Involved Lottery for 55 Conditional Adult-Use Cannabis Dispensary Licenses (Conditional Licenses) across the state. The certified results are from a lottery with a pool of applicants who scored 85% or greater in their applications. NMG IL 1 and NMG IL 4 were drawn in BLS Region #5 (Chicago-Naperville-Elgin) where 36 conditional licenses are available. The applications are not tied to specified locations. The Transaction with NMG IL 4 was completed on 25 April 2023 (Note 9). The final ownership changes are currently under review by the state and anticipated to be approved in the near term. The Transaction with NMG IL 1, following the same pattern described in Note 9, has not been completed as of the date of these financial statements. |
Discontinued Operations and Ass
Discontinued Operations and Assets Held for Sale | 12 Months Ended |
Jul. 31, 2023 | |
Discontinued Operations and Assets Held for Sale | |
Discontinued Operations and Assets Held for Sale | 19. Discontinued Operations and Assets Held for Sale The following table summarizes the Company's loss from discontinued operations for the years ended July 31, 2023 and 2022. The gain and loss resulting from the forgiveness of intercompany payables has been eliminated in consolidation. 2023 2022 Sales $ 7,364,410 $ 8,265,339 Cost of sales (4,398,644 ) (4,768,324 ) Gross profit 2,965,766 3,497,015 Operating expenses (2,479,390 ) (2,504,514 ) Other items (13,406 ) (60,928 ) Impairment of Michigan assets (944,015 ) - (3,436,811 ) (2,565,442 ) Income (loss) from discontinued operations before income taxes $ (471,045 ) $ 931,573 Income tax expense (82,744 ) (744,323 ) Net income (loss) from discontinued operations (553,789 ) 187,250 The assets and liabilities associated with discontinued operations consisted of the following as of July 31, 2023 and 2023: 2023 2022 Assets associated with discontinued operations Cash $ 164,882 $ 385,176 Accounts receivable 20,335 36,740 Prepaids 238,756 217,566 Inventory 208,794 314,570 Property and equipment, net 1,143,818 1,920,249 Operating lease right-of-use assets 356,748 890,962 Brand and licenses, net 1,897,295 2,177,141 Total assets associated with discontinued operations 4,030,628 5,942,404 Liabilities associated with discontinued operations Accounts payables and accrued liabilities 214,129 307,415 Operating lease liabilities 365,170 771,667 Total liabilities associated with discontinued operations $ 579,299 $ 1,079,082 Total assets and liabilities associated with discontinued operations are presented as current assets and liabilities, respectively, due to the fact that they are likely to be sold within 12 months. A reconciliation of the beginning and ending balances of assets held for sale during the year ended 31 July 2023 and 2022 is as follows: Available for Sale Subsidiaries Discontinued Operations Total Balance as of 31 July 2021 $ 3,939,208 $ - $ 3,939,208 Transferred in 1,230,011 1,178,794 2,408,805 Ongoing activity from discontinued operations (405,609 ) - (405,609 ) Balance as of 31 July 2022 4,763,610 1,178,794 5,942,404 Ongoing activity from discontinued operations (732,982 ) - (732,982 ) Disposition - (1,178,794 ) (1,178,794 ) Balance as of 31 July 2023 $ 4,030,628 $ - $ 4,030,628 Available for Sale Subsidiaries In July 2023 and August 2023, the Company approved the sale of the Ohio operations. NMG OH 1 disposition The company entered into an equity purchase agreement (the “EPA”) dated 21 July 2023, between the Company’s wholly owned subsidiary, DEP Nevada, NMG OH 1 and FarmaceuticalRX, LLC (the “Purchaser”), DEP sold all of the issued and outstanding interests and other ownership, equity or profits interests in NMG OH 1 to the Purchaser. On 17 October 2023, pursuant to (the “Disposition”). Pursuant to the closing of the Disposition, on 17 October 2023 (the “Closing Date”), the Purchaser paid an initial total consideration of US$8.225 million (US$7,975,000 on closing plus US$250,000 deposit upon signing of the EPA) (the “Initial Purchase Price”) in cash to DEP Nevada, which Initial Purchase Price is subject to a working capital adjustment and other customary adjustments pursuant to the EPA to be calculated within 365 days of the Closing Date (the “Final Purchase Price”). Also see Note 21. Membership Interest Purchase Agreement (NMG OH P1) On September 5, 2023, DEP entered into a membership interest purchase agreement (the “NMG OH P1 Purchase Agreement”) with LMTB LLC, an Ohio limited liability company (the “LMTB”), pursuant to which DEP will sell the issued and outstanding membership interests (the “NMG OH P1 Interests”) in NMG OH P1 to LMTB for the purchase price of US$2,000,000, subject to adjustment in the event that NMG OH P1’s Working Capital (as defined in the NMG OH P1 Purchase Agreement) on the NMG OH P1 Closing Date (as hereinafter defined) varies from the Target Working Capital (as defined in the NMG OH P1 Purchase Agreement and thereby fixed at zero (0) dollars). An amount equal to the Deposit (as defined in the NMG OH P1 Purchase Agreement), being US$1,000,000, shall be held in escrow by Murphy Schiller & Wilkes LLP as escrow agent (the “NMG OH P1 Escrow Agent”) pursuant to the terms and conditions of an escrow agreement entered into among DEP, NMG OH P1 and LMTB contemporaneously with the NMG OH P1 Purchase Agreement. Discontinued Operations In April 2023, the Company approved the sale of the Michigan retail operation, which was completed in June 2023. Assets held for sale related to Ohio operations and Michigan retail operation represent a strategic shift in the Company's operations and therefore is classified as available for sale subsidiaries and discontinued operations as of 31 July 2023. During the year ended 31 July 2023, the Company performed an analysis of any impairments prior to reclassifying certain assets as held for sale and recorded an impairment of $944,015 which is included as a component of loss on impairment in the consolidated statements of operations and comprehensive loss. |
Income Taxes
Income Taxes | 12 Months Ended |
Jul. 31, 2023 | |
Income Taxes | |
Income Taxes | 20. Income Taxes The components of the income tax expense for continuing operations consisted of the following: 2023 2022 Current: Federal $ 2,588,522 $ 1,540,516 State 7,471 61,153 2,595,993 1,601,669 Deferred: Federal (427,507 ) 4,787 State - 168,153 (427,507 ) 172,940 Total expense for income taxes $ 2,168,486 $ 1,774,609 Section 280E of the Internal Revenue Code (“IRC”) prohibits businesses engaged in the trafficking of Schedule I or Schedule II controlled substances from deducting normal business expenses, such as payroll and rent, from gross income (revenue less cost of goods sold). Section 280E was originally intended to penalize criminal market operators, but because cannabis remains a Schedule I controlled substance for U.S. Federal purposes, the Internal Revenue Service (the “IRS”) has subsequently applied Section 280E to state-legal cannabis businesses. Cannabis businesses operating in states that align their tax codes with the IRC are also unable to deduct normal business expenses from their state taxes. The nondeductible expenses shown in the effective rate reconciliation above is comprised primarily of the impact of applying Section 280E to the Company’s businesses that are involved in selling cannabis, along with other typical non-deductible expenses such as lobbying expenses. The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% and the reported income tax (benefit) expense are summarized below: 2023 2022 Net loss for the year before income tax $ (18,154,204 ) $ (26,640,745 ) Federal and state income tax rates 21.00 % 21.00 % Expected income tax recovery (3,806,994 ) (5,594,555 ) State taxes (615,593 ) (474,933 ) Stock options - 118,816 IRC 280E disallowance 4,318,695 7,648,632 Deferred tax adjustment (757,256 ) (585,809 ) Return to provision (1,543,140 ) - Valuation allowance 968,717 724,287 Change in state tax rate (186,076 ) - Uncertain tax position 3,790,133 - Other - (61,829 ) Total income tax expense $ 2,168,486 $ 1,774,609 The impact of the loss on impairment of goodwill, intangible assets, ROU assets, and loans receivable in the aggregate amount of $9,370,092 is included in the IRC 280E disallowance for 2023. Approximately $19 million was included in the IRC 280E disallowance for the year ended 31 July 2023 related to the impairment losses. The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities were as follows: As at 31 July 2023 As at 31 July 2022 Deferred income tax asset Fixed assets $ 98,512 $ - Brand and license 605,980 559,032 Lease liabilities 595,496 342,437 Investments 263,188 126,395 Net operating loss carryforwards 775,060 276,739 Gross deferred tax assets 2,338,236 1,304,602 Less: valuation allowance (1,854,715 ) (854,143 ) Total deferred tax assets $ 483,521 $ 450,459 Deferred tax liabilities: Inventory $ - $ 541,689 Right-of-use assets 483,521 232,939 FY 21 & FY 22 481(a) Adjustment - - Fixed assets - 103,601 Total deferred tax liabilities $ 483,521 $ 878,229 Net deferred tax liabilities $ - $ (427,770 ) Management regularly assesses the ability to realize deferred tax assets recorded based upon the weight of available evidence, including such factors as recent earnings history and expected future taxable income on a jurisdiction by jurisdiction basis. In the event that the Company changes its determination as to the amount of realizable deferred tax assets, the Company will adjust its valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made. The Company’s management believes that, based on a number of factors, it is more likely than not, that all or some portion of the deferred tax assets will not be realized; and accordingly, for the fiscal year ended 31 July 2023, the Company has provided a valuation allowance against the Company’s U.S. net deferred tax assets. The net change in the valuation allowance for the fiscal year ended 31 July 2023 was an increase/(decrease) of $1,000,572. The Company had net operating loss (“NOL”) carryforwards for federal and state income tax purposes of approximately $Nil and $9,092,933, respectively, as of 31 July 2023. State NOL will begin to expire in 2042 and $Nil of the Company's federal NOL will last indefinitely (limited to 80% of taxable income in a given year). The Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of net operating losses in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use net operating losses may be limited as prescribed under Internal Revenue Code Section 382 (“IRC Section 382”). Events which may cause limitations in the amount of the net operating losses that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the federal and state net operating losses may be subject to substantial annual limitation due to the ownership change limitations provided by the IRC Section 382 and similar state provisions. The Company may, in the future, experience one or more additional Section 382 “ownership changes.” If so, the Company may not be able to utilize some of its carryforwards or other tax attributes, even if the Company achieves profitability in the jurisdiction of the carryforwards or other tax attributes. The Company has not completed a study to assess whether a change of ownership has occurred, or whether there have been multiple ownership changes since its formation, due to the significant cost and complexity associated with such a study. Any limitation may result in expiration of a portion of the NOL carryforwards before utilization. Further, until a study is completed by the Company and any limitation is known, no amounts are being presented as an uncertain tax position. As of 31 July 2023, the total amount of gross unrecognized tax benefits was $3,648,717, which includes interest and penalties. As of 31 July 2023, $3,648,717 of the total unrecognized tax benefits, if recognized, would have an impact on the Company's effective tax rate. The Company estimates that approximately $591,087 of unrecognized tax benefits, including penalties and interest, may be recognized in the next 12 months. The Company files income tax returns in the U.S. federal jurisdiction, California, and Michigan and locally in Ohio. The Company’s tax years for 2019 and forward are subject to examination by the US tax authorities. The Company’s tax years for 2019 and forward are subject to examination by various state tax authorities. Following is a reconciliation of gross unrecognized tax benefits from uncertain tax positions, excluding the impact of penalties and interest. The tax accounting method was changed to the Farm Price method which allows a more granular assessment of each expense, for the cultivation and manufacturing operations only, to be applied and expensed as cost of goods, to determine net taxable income. As at 31 July 2023 As at 31 July 2022 Beginning year balance $ 966,992 $ 996,992 Increase in balance related to tax positions taken during current year 1,068,590 - Decrease in balance as a result of a lapse of the applicable statute of limitations (406,508 ) - Increase in balance related to tax positions taken during prior years 2,019,643 - Net deferred income tax liability $ 3,648,717 $ 996,992 On 27 March 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), P.L. 116-136, was passed into law, amending portions of relevant US tax laws, including the Tax Cuts and Jobs Act enacted and accounted for in FY18. Some of the laws that were revised were the IRC 163(j) interest expense limitation; net operating loss carryback, carryforward, and utilization rules; and qualified improvement property depreciation methods. As the CARES Act was enacted prior to the Company’s year-end, the Company has accounted for all of the applicable changes in tax law in the consolidated statement of operations for the years ended 31 July 2023 and 2022 and has determined that any impact is not material to its financial statements. Beginning on 1 January 2022, the Tax Cuts and Jobs Act (“the Act”), enacted in December 2017, eliminated the option to deduct research and development expenditures in the current period and requires taxpayers to capitalize and amortize U.S.-based and non-U.S. based research and development expenditures over five and fifteen years, respectively. There is no impact to our current income tax provision as a result of this tax legislation. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Jul. 31, 2023 | |
Subsequent Events | |
Subsequent Event | 21. Subsequent Events Convertible Loan Agreement Assignment On or around August 22, 2023, DEP assigned the Convertible Loan Agreement to a related entity, Big Stone Farms AR 1, LLC, an Arkansas limited liability company, which is wholly owned by the Company’s Chief Operating Officer and Director, in exchange for an option to purchase the outstanding interests of Big Stone Farms AR 1, LLC for a purchase price of $1.00. Membership Interest Purchase Agreement (NMG OH P1) On September 5, 2023, DEP entered into a membership interest purchase agreement (the “NMG OH P1 Purchase Agreement”) with LMTB LLC, an Ohio limited liability company (the “LMTB”), pursuant to which DEP will sell the issued and outstanding membership interests (the “NMG OH P1 Interests”) in NMG OH P1 to LMTB for the purchase price of US$2,000,000, subject to adjustment in the event that NMG OH P1’s Working Capital (as defined in the NMG OH P1 Purchase Agreement) on the NMG OH P1 Closing Date (as hereinafter defined) varies from the Target Working Capital (as defined in the NMG OH P1 Purchase Agreement and thereby fixed at zero (0) dollars). An amount equal to the Deposit (as defined in the NMG OH P1 Purchase Agreement), being US$1,000,000, shall be held in escrow by Murphy Schiller & Wilkes LLP as escrow agent (the “NMG OH P1 Escrow Agent”) pursuant to the terms and conditions of an escrow agreement entered into among DEP, NMG OH P1 and LMTB contemporaneously with the NMG OH P1 Purchase Agreement. Closing of Equity Purchase Agreement (NMG OH 1) On 17 October 2023, pursuant to equity purchase agreement (the “EPA”) dated 21 July 2023, between the Company’s wholly owned subsidiary, DEP Nevada, NMG OH 1 and FarmaceuticalRX, LLC (the “Purchaser”), DEP sold all of the issued and outstanding interests and other ownership, equity or profits interests in NMG OH 1 to the Purchaser (the “Disposition”). Pursuant to the closing of the Disposition, on 17 October 2023 (the “Closing Date”), the Purchaser paid an initial total consideration of US$8.225 million (US$7,975,000 on closing plus US$250,000 deposit upon signing of the EPA) (the “Initial Purchase Price”) in cash to DEP Nevada, which Initial Purchase Price is subject to a working capital adjustment and other customary adjustments pursuant to the EPA to be calculated within 365 days of the Closing Date (the “Final Purchase Price”). Based on the Accepted Adjustment Statement (as defined in the EPA), the parties shall determine if the Final Purchaser Price shall be adjusted upwards or downwards. An amount equal to the Escrow Amount (as defined in the EPA) of US$100,000 from the Final Purchase Price is being held in escrow and will be released to DEP Nevada on the fifth day of the twelfth month after the Closing Date unless there are any indemnification claims pending until such time as the claim is resolved. In addition, DEP Nevada shall receive a payment of US$2,500,000 (each, a “Bonus Payment”) for each additional dispensary license granted to NMG OH 1 by the State of Ohio Board of Pharmacy or other regulatory body, in accordance with the terms of the EPA. Additional dispensary licenses that will receive the Bonus Payment shall specifically exclude an adult use license issued for the License (as defined in the EPA) and current lease location. Simultaneously with the closing of the EPA, the Company used US$7.33 million of the Initial Purchase Price funds to fully repay the debt owing to its senior secured lender. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 12 Months Ended |
Jul. 31, 2023 | |
Significant Accounting Policies | |
Basis of presentation | These condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and are expressed in U.S. dollars. The Company’s fiscal year end is 31 July. |
Amounts receivable | Amounts receivable represents amounts owed from customers for sale of medical and recreational cannabis and sales tax recoverable. Amounts are presented net of the allowance for doubtful accounts, which represents the Company’s best estimate of the amount of probable credit losses in the existing accounts receivable balance. The Company determines the allowance for doubtful accounts based on historical experience and current economic conditions. The Company reviews the adequacy of its allowance for doubtful accounts on a quarterly basis. As of 31 July 2023 and 2022, the Company has no allowance for doubtful accounts. |
Revenue recognition | The Company recognizes revenue from product sales when our customers obtain control of our products. This determination is based on the customer specific terms of the arrangement for wholesale operations. Upon transfer of control, the Company has no further performance obligations. All retail sales are considered cash on delivery. Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC 606. The Company’s revenues accounted for under ASC 606, generally, do not require significant estimates or judgments based on the nature of the Company’s revenue streams. The sales prices are generally fixed and all consideration from contracts is included in the transaction price. The Company’s contracts do not include multiple performance obligations or material variable consideration. See Note 15 for revenue disaggregation table. |
Inventory and cost of goods sold | Inventory consists of work in progress (live plants and plants in the drying process), finished goods, and consumables. The Company values its finished goods and consumables at the lower of the actual costs or its current estimated market value less costs to sell. The Company values its work in progress at cost using the average cost method. Costs incurred during the growing and production process are capitalized as incurred to the extent that cost is less than net realizable value. These costs include materials, labor and manufacturing overhead used in the growing and production processes. The Company capitalizes pre-harvest costs. The Company periodically reviews its inventory for obsolete and potentially impaired items. Any identified slow moving and obsolete items are written down to its net realizable value through a charge to cost of goods sold. As of 31 July 2023 and 2022, the Company has no allowance for inventory obsolescence. Cost of goods sold includes the costs directly attributable to product sales and includes amounts paid for finished goods, such as flower, edibles and concentrates, packaging and other supplies, fees for services and processing, and allocated overhead, such as allocations of rent, administrative salaries, utilities and related costs. |
Loans receivable | The Company carries its loans receivable at cost and are reviewed for indicators of impairment at least annually. |
Property and equipment | Property and equipment are stated at cost and are amortized over their estimated useful lives on a straight-line basis as follows: Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease |
Intangible assets | Intangible assets acquired from third parties are measured initially at fair value and either classified as indefinite life or finite life depending on their characteristics. Intangible assets with indefinite lives are tested for impairment at least annually and intangible assets with finite lives are reviewed for indicators of impairment at least annually. The Company’s brands and licenses acquired from NMG have indefinite lives; therefore, no amortization is recognized. The Company’s brands and licenses acquired by NMG SD have a finite life of 10 years, brands and licenses acquired by NMG LB and NMG OH 1 have a finite life of 10 years, customer relationships acquired by NMG OH 1 have a finite life of five years, licenses acquired by Canopy have a finite life of 10 years and are amortized over these estimated useful lives on a straight-line basis. Brands acquired by Canopy have indefinite lives. |
Impairment of long-lived assets | The Company reviews long-lived assets, including property and equipment and definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. |
Impairment of goodwill and indefinite-lived assets | Goodwill and indefinite-lived intangible assets are not amortized. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying amount in accordance with the provisions of ASC 350, “Intangibles—Goodwill and Other”. The Company performs an impairment test annually by comparing the fair value of the indefinite-lived intangible assets or reporting unit (for goodwill) with its carrying amount. The measurement of the impairment loss to be recognized is based on the amount by which the carrying amount exceeds the reporting unit’s fair value. |
Income taxes | Deferred income taxes are reported for timing differences between items of income or expense reported in the consolidated financial statements and those reported for income tax purposes in accordance with ASC 740, “Income Taxes”, which requires the use of the asset/liability method of accounting for income taxes. Deferred income taxes and tax benefits are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases, and for tax losses and credit carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company provides for deferred taxes for the estimated future tax effects attributable to temporary differences and carry-forwards when realization is more likely than not. The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of operations and comprehensive income. |
Basic and diluted net income (loss) per share | The Company computes net income (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive. As of 31 July 2023, potential common shares are comprised of 17,151,000 outstanding options, 33,215,284 outstanding warrants and 31,472,877 shares issuable on conversion of convertible debentures. |
Comprehensive loss | ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive income/loss and its components in the consolidated financial statements. As of 31 July 2023 and 2022, the Company reported foreign currency translation adjustments as other comprehensive income or loss and included a schedule of comprehensive income/loss in the consolidated financial statements. |
Foreign currency translation | The Company’s functional currency is the Canadian dollar and its reporting currency is in U.S. dollars. The Company’s subsidiaries have a functional currency in U.S. dollars. The consolidated financial statements of the Company are translated to U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. Exchange gains and losses on inter-company balances that form part of the net investment in foreign operations are included in other comprehensive income. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. The exchange rates used to translate Canadian dollar to U.S. dollar was 0.7589 for monetary assets and liabilities and 0.7455 as an average rate for transactions occurred during the year ended 31 July 2023. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the determination of net loss. |
Stock based compensation | The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes Option Pricing Model. The fair value determined represents the cost for the award and is recognized over the required service period, generally defined as the vesting period. The Company’s accounting policy is to recognize forfeitures as they occur. |
Fair value measurements | The Company accounts for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are: · Level 1 – inputs are based upon unadjusted quoted prices for identical instruments in active markets. · Level 2 – inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. · Level 3 – inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in other private entities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities. The Company measures equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. The convertible loan receivable was valued using Level 3 inputs. Other current financial assets and current financial liabilities have fair values that approximate their carrying values. |
Use of estimates and assumptions | The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities, if any, at the date of the consolidated financial statements and the reported amounts of revenues and expenditures during the reporting period. Actual results could differ from these estimates. |
Lease accounting | Under ASC 842, leases are separated into two classifications: operating leases and financial leases. Lease classification under ASC 842 is relatively similar to ASC 840. For a lease to be classified as a finance lease, it must meet one of the five finance lease criteria: (1) transference of title/ownership to the lessee, (2) purchase option, (3) lease term for major part of the remaining economic life of the asset, (4) present value represents substantially all of the fair value of the asset, and (5) asset specialization. Any lease that does not meet these criteria is classified as an operating lease. ASC 842 requires all leases to be recognized on the Company’s balance sheet. Specifically, for operating leases, the Company recognize a right-of-use asset and a corresponding lease liability upon lease commitment. |
Non-controlling Interest | Non-controlling interests (“NCI”) represent equity interests owned by outside parties. NCI may be initially measured at fair value or at the NCI’s proportionate share of the recognized amounts of the acquiree's identifiable net assets. The choice of measurement is made on a transaction-by-transaction basis. The Company has elected to measure each NCI at its proportionate share of the recognized amounts of the acquiree’s identifiable net assets. The share of net assets attributable to NCI are presented as a component of equity. NCI's share of net income or loss is recognized directly in equity. Total income or loss of subsidiaries is attributed to the shareholders of the Company and to the NCI, even if this results in the NCI having a deficit balance. |
Assets and liabilities held for sale | The Company classifies assets held for sale in accordance with ASC 360, “Property, Plant and Equipment”. When the Company makes the decision to sell an asset or to stop some part of its business, the Company assesses if such assets should be classified as an asset held for sale. To classify as an asset held for sale, the asset or disposal group must meet all of the following conditions: i) management, having the authority to approve the action, commits to a plan to sell the asset, ii) the asset is available for immediate sale in its present condition subject to certain customary terms, iii) an active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated, iv) the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale, within one year, subject to certain exceptions, v) the asset is being actively marketed for sale at a price that is reasonable in relation to its current value, and vi) actions required to complete the plan indicate that it is unlikely that the plan will be significantly changed or withdrawn. Assets held for sale are measured at the lower of their carrying amount or fair value less cost to sell (“FVLCTS”). FVLCTS is the amount obtainable from the sale of the asset in an arm’s length transaction, less the costs of disposal. Once classified as held for sale, any depreciation and amortization on an asset cease to be recorded. For long-lived assets or disposals groups that are classified as held for sale but do not meet the criteria for discontinued operations, the assets and liabilities are presented separately on the balance sheet of the initial period in which it is classified as held for sale. The major classes of assets and liabilities classified as held for sale are disclosed in the notes to the consolidated financial statements. |
Nature and Continuance of Ope_2
Nature and Continuance of Operations (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Nature and Continuance of Operations | |
Schedule of subsidiaries of company | Name Jurisdiction Ownership Date of acquisition or formation DEP Nevada Inc. (“DEP Nevada”) Nevada, USA 100 % 10 August 2017 Nevada Medical Group LLC (“NMG”) Nevada, USA 100 % 14 November 2017 NMG Long Beach LLC (“NMG LB”) California, USA 100 % 18 December 2018 NMG San Diego LLC (“NMG SD”) California, USA 60 % 30 January 2019 NMG Ohio LLC (“NMG Ohio”) Ohio, USA 100 % 27 April 2017 NMG OH 1, LLC (“NMG OH 1”) Ohio, USA 100 % 30 January 2020 NMG OH P1, LLC (“NMG OH P1”) Ohio, USA 100 % 30 January 2020 NMG MI 1, Inc. (“NMG MI 1”) Michigan, USA 100 % 24 June 2021 NMG MI C1 Inc. Michigan, USA 100 % 24 June 2021 NMG MI P1 Inc. Michigan, USA 100 % 24 June 2021 Canopy Monterey Bay, LLC (“Canopy”) California, USA 100 % 30 November 2021 NMG CA P1, LLC (“NMG CA P1”) California, USA 100 % 7 January 2020 NMG CA C1, LLC (“NMG CA C1”) California, USA 100 % 7 October 2020 BaM Body and Mind Dispensary NJ, Inc. (“BAM NJ”) New Jersey, USA 100 % 21 December 2022 NMG IL4, LLC (“NMG IL 4”) Illinois, USA 100 % 25 April 2023 |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Significant Accounting Policies | |
Schedule of property and equipment estimated useful lives | Office equipment 7 years Cultivation equipment 7 years Production equipment 7 years Kitchen equipment 7 years Vehicles 7 years Vault equipment 7 years Leasehold improvements shorter of useful life or the term of the lease |
Financial Instruments (Tables)
Financial Instruments (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Financial Instruments | |
Schedule of financial assets at fair value | As of 31 July 2023 As of 31 July 2022 Financial assets at fair value Cash $ 1,511,051 $ 1,854,277 Convertible loan receivable 1,700,411 1,250,000 Total financial assets at fair value $ 3,211,462 $ 3,104,277 |
Inventory (Tables)
Inventory (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Inventory | |
Schedule of inventory | 31 July 2023 31 July 2022 Work in progress $ 652,825 $ 610,030 Finished goods 604,519 1,961,244 Consumables 1,053,257 1,308,726 Total $ 2,310,601 $ 3,880,000 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Property and Equipment | |
Schedule of property and equipment | Office Equipment Cultivation Equipment Production Equipment Kitchen Equipment Vehicles Vault Equipment Leasehold Improvements Total Cost: Balance, 31 July 2022 $ 333,689 $ 466,110 $ 581,335 $ 63,102 $ 38,717 $ 10,335 $ 4,487,002 $ 5,980,290 Additions 25,183 - - - - - 967,701 992,884 Impairment (295,980 ) (466,110 ) (345,650 ) (41,050 ) (38,717 ) (2,172 ) (3,304,042 ) (4,493,721 ) Balance, 31 July 2023 62,892 - 235,685 22,052 - 8,163 2,150,661 2,479,453 Accumulated Depreciation: Balance, 31 July 2022 61,761 318,856 290,729 29,880 29,859 3,266 1,525,654 2,260,005 Depreciation 49,469 68,312 81,322 9,014 5,531 1,476 565,909 781,033 Impairment (85,525 ) (387,168 ) (251,572 ) (26,285 ) (35,390 ) (1,828 ) (1,601,032 ) (2,388,800 ) Balance, 31 July 2023 25,705 - 120,479 12,609 - 2,914 490,531 652,238 Net Book Value: At 31 July 2022 271,928 147,254 290,606 33,222 8,858 7,069 2,961,348 3,720,285 At 31 July 2023 $ 37,187 $ - $ 115,206 $ 9,443 $ - $ 5,249 $ 1,660,130 $ 1,827,215 |
Acquisitions (Tables)
Acquisitions (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Summary of pro forma information | Year ended 31 July 2022 As Reported Pro Forma (unaudited) Revenue $ 23,372,823 $ 26,661,994 Net loss (28,228,104 ) (28,212,341 ) |
NMG IL 4, LLC [Member] | |
Schedule of Purchase consideration | Assets acquired: Cash 100,707 Prepaid and deposits 70,230 Inventory 194,075 Property and equipment 918,492 Liabilities assumed: Trade payable and accrued liabilities (288,469 ) Net assets acquired $ 995,035 |
Canopy Monterey Bay, LLC [Member] | |
Schedule of Purchase consideration | Purchase consideration Cash $ 1,250,000 Promissory note 2,300,000 Shares of common stock (Note 14) 2,189,544 Contingent consideration 100,000 Total consideration 5,839,544 Assets acquired: Cash 378,503 Prepaid expenses 241,449 Inventory 630,039 Liabilities assumed: Trade payable and accrued liabilities (266,307 ) Income taxes payable (1,229,213 ) Net assets acquired (245,529 ) Brand and licenses 1,240,000 Goodwill 4,845,073 TOTAL $ 5,839,544 |
Intangible Assets Net (Tables)
Intangible Assets Net (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Intangible Assets Net | |
Schedule of intangible assets | As of 31 July 2023 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 370,000 - $ - $ 370,000 Licenses 4,683,508 10.0 (1,053,576 ) 3,629,932 Total intangible assets $ 5,053,508 $ (1,053,576 ) $ 3,999,932 As of 31 July 2022 Gross carrying amount Weighted average life (years) Accumulated amortization Net carrying amount Amortizable intangible assets: Brand $ 425,000 - $ - $ 425,000 Licenses 11,193,508 10.0 (1,934,334 ) 9,259,174 Total intangible assets $ 11,618,508 $ (1,934,334 ) $ 9,684,174 |
Schedule of intangible assets future amortization expense | Presented based on fiscal year 2024 $ 371,631 2025 370,616 2026 370,616 2027 370,616 2028 371,632 Thereafter 1,774,821 $ 3,629,932 |
Related Party Balances and Tr_2
Related Party Balances and Transactions (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Related Party Balances and Transactions | |
Schedule of related party transactions | For the year ended 31 July 2023 For the year ended 31 July 2022 A company controlled by the President, Chief Executive Officer and a director Management fees $ 212,505 $ 284,533 A company controlled by the Chief Financial Officer and a director Management fees 81,614 134,693 A company controlled by the Corporate Secretary Management fees 56,647 87,748 $ 350,766 $ 506,974 |
Loans Payable and Convertible_2
Loans Payable and Convertible Debenture (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Loans Payable and Convertible Debenture | |
Schedule of Loan | 31 July 2023 31 July 2022 FocusGrowth loan $ 6,666,667 $ 6,666,667 Long Beach loan 10,728 12,535 Canopy loan Secured promissory note 2,300,000 2,300,000 Unsecured loan balance 7,052 - CCG loan 148,221 - Total principal amount $ 9,132,668 $ 8,979,202 Debt discount (1,187,008 ) (1,573,031 ) Outstanding balance, net $ 7,945,660 $ 7,406,171 Current portion (166,001 ) (12,535 ) Long-term portion $ 7,779,659 $ 7,393,636 |
Schedule of Convertible Debenture Financing | 31 July 2023 31 July 2022 BAM I, A Series of Bengal Catalyst Fund SPV, LP (related party – Note 9) $ 2,750,000 $ - Mindset Value Fund LP 150,000 - Mindset Value Wellness Fund LP 100,000 - Total principal amount $ 3,000,000 $ - Debt discount (519,478 ) - Outstanding balance, net $ 2,480,522 $ - |
Operating leases (Tables)
Operating leases (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Operating Leases | |
Schedule of supplemental cash flow information related to leases | Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,582,411 Weighted-average remaining lease term – operating leases 7.03 years Weighted-average discount rate – operating leases 12 % |
Schedule of maturities of lease liabilities | Year Ending 31 July Operating Leases 2024 $ 2,114,388 2025 2,026,131 2026 1,978,981 2027 1,677,468 2028 and thereafter 5,700,655 Total lease payments $ 13,497,623 Less imputed interest (4,538,918 ) Total $ 8,958,705 Less current portion (1,099,888 ) Long term portion $ 7,858,817 |
Schedule of right-of-use assets and the lease liabilities | 31 July 2023 31 July 2022 NMG OH 1 – right-of-use assets $ 158,336 $ 188,165 NMG OH P1 – right-of-use assets $ 198,412 $ 223,527 NMG OH 1 – lease liabilities $ 162,552 $ 191,529 NMG OH P1 – lease liabilities $ 202,618 $ 226,303 |
Capital Stock (Tables)
Capital Stock (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Schedule of stock option activity | Number of options Weighted average exercise price Weighted average contractual term remaining (in years) Aggregate intrinsic value Outstanding at 31 July 2021 9,855,000 CAD$0.71 2.76 CAD$ - Granted 848,000 CAD$0.37 CAD$ - Cancelled (1,250,000 ) CAD$0.70 CAD$ - Outstanding at 31 July 2022 9,453,000 CAD$0.67 2.11 CAD$ - Granted 9,773,000 CAD$0.07 CAD$ - Expired (2,075,000 ) CAD$0.64 CAD$ - Outstanding at 31 July 2023 17,151,000 CAD$0.33 3.16 CAD$ - Vested and fully exercisable at 31 July 2023 12,989,000 CAD$0.41 2.69 CAD$ - |
Schedule of number of options outstanding and exercisable | Number of options outstanding Number of options exercisable Exercise price Expiry dates 775,000 775,000 CAD$0.57 10 December 2023 1,600,000 1,600,000 CAD$0.88 21 August 2024 250,000 250,000 CAD$0.93 1 October 2024 200,000 200,000 CAD$0.88 23 January 2025 250,000 250,000 CAD$0.405 1 March 2025 1,375,000 1,375,000 CAD$0.67 30 April 2025 350,000 350,000 CAD$0.88 21 August 2024 150,000 150,000 CAD$0.61 10 December 2023 80,000 80,000 CAD$0.57 10 December 2023 1,250,000 1,250,000 CAD$0.68 6 March 2026 250,000 250,000 CAD$0.65 5 April 2024 448,000 336,000 CAD$0.44 30 November 2026 200,000 200,000 CAD$0.44 30 November 2024 200,000 200,000 CAD$0.15 8 July 2027 4,050,000 - CAD$0.065 25 April 2028 5,723,000 5,723,000 CAD$0.065 25 April 2028 17,151,000 12,989,000 |
Schedule of Share purchase warrants and brokers' warrants | Number of warrants Weighted average exercise price Outstanding at 31 July 2021 17,215,284 CAD$1.21 Issued 1,000,000 USD$0.16 Outstanding at 31 July 2022 18,215,284 CAD$1.16 Issued 15,000,000 USD$0.10 Expired (12,415,284 ) CAD$1.49 Outstanding at 31 July 2023 20,800,000 CAD$0.23 |
Schedule of number of warrants outstanding and exercisable | Number of warrants outstanding and exercisable Exercise price Expiry dates 4,800,000 USD$0.40 19 July 2025 15,000,000 USD$0.10 19 December 2026 1,000,000 USD$0.16 14 June 2027 20,800,000 CAD$0.23 Number of warrants outstanding and exercisable Exercise price Expiry dates 11,780,134 CAD$1.50 17 May 2023 635,150 CAD$1.25 16 May 2023 4,800,000 USD$0.40 19 July 2025 1,000,000 USD$0.16 14 June 2027 18,215,284 CAD$1.16 |
Warrant [Member] | |
Schedule of weighted average assumptions | Expected life of the options 4 years Expected volatility 107 % Expected dividend yield 0 % Risk-free interest rate 3.03 % |
Options [Member] | |
Schedule of weighted average assumptions | Expected life of the options 2.76 years Expected volatility 103 % Expected dividend yield Nil Risk-free interest rate 3.27 % |
Segmented Information and Maj_2
Segmented Information and Major Customers (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Segmented Information and Major Customers | |
Schedule of Segment revenue and net loss | 31 July 2023 Revenue Wholesale $ 5,070,441 Retail 17,749,542 Total $ 22,819,983 Net loss before taxes Wholesale $ (5,520,602 ) Retail (5,321,539 ) All others (7,312,063 ) Total $ (18,154,204 ) |
Supplemental Disclosures with_2
Supplemental Disclosures with Respect to Cash Flows (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Supplemental Disclosures with Respect to Cash Flows | |
Schedule of supplemental disclosures with respect to cash flows | Year Ended 31 July 2023 2022 Cash paid during the period for interest $ 1,037,208 $ 876,364 Cash paid during the period for income taxes $ 25,663 $ 3,436,572 |
Discontinued Operations and A_2
Discontinued Operations and Assets Held for Sale (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Discontinued Operations and Assets Held for Sale | |
Schedule of loss from discontinued operations | 2023 2022 Sales $ 7,364,410 $ 8,265,339 Cost of sales (4,398,644 ) (4,768,324 ) Gross profit 2,965,766 3,497,015 Operating expenses (2,479,390 ) (2,504,514 ) Other items (13,406 ) (60,928 ) Impairment of Michigan assets (944,015 ) - (3,436,811 ) (2,565,442 ) Income (loss) from discontinued operations before income taxes $ (471,045 ) $ 931,573 Income tax expense (82,744 ) (744,323 ) Net income (loss) from discontinued operations (553,789 ) 187,250 |
Schedule of assets and liabilities with discontinued operations | 2023 2022 Assets associated with discontinued operations Cash $ 164,882 $ 385,176 Accounts receivable 20,335 36,740 Prepaids 238,756 217,566 Inventory 208,794 314,570 Property and equipment, net 1,143,818 1,920,249 Operating lease right-of-use assets 356,748 890,962 Brand and licenses, net 1,897,295 2,177,141 Total assets associated with discontinued operations 4,030,628 5,942,404 Liabilities associated with discontinued operations Accounts payables and accrued liabilities 214,129 307,415 Operating lease liabilities 365,170 771,667 Total liabilities associated with discontinued operations $ 579,299 $ 1,079,082 |
Schedule of reconciliation of beginning and ending balances of assets held for sale | Available for Sale Subsidiaries Discontinued Operations Total Balance as of 31 July 2021 $ 3,939,208 $ - $ 3,939,208 Transferred in 1,230,011 1,178,794 2,408,805 Ongoing activity from discontinued operations (405,609 ) - (405,609 ) Balance as of 31 July 2022 4,763,610 1,178,794 5,942,404 Ongoing activity from discontinued operations (732,982 ) - (732,982 ) Disposition - (1,178,794 ) (1,178,794 ) Balance as of 31 July 2023 $ 4,030,628 $ - $ 4,030,628 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Jul. 31, 2023 | |
Income Taxes | |
Schedule of reconciliation of income taxes | 2023 2022 Current: Federal $ 2,588,522 $ 1,540,516 State 7,471 61,153 2,595,993 1,601,669 Deferred: Federal (427,507 ) 4,787 State - 168,153 (427,507 ) 172,940 Total expense for income taxes $ 2,168,486 $ 1,774,609 |
Schedule of non-deductible expenses such as lobbying expenses | 2023 2022 Net loss for the year before income tax $ (18,154,204 ) $ (26,640,745 ) Federal and state income tax rates 21.00 % 21.00 % Expected income tax recovery (3,806,994 ) (5,594,555 ) State taxes (615,593 ) (474,933 ) Stock options - 118,816 IRC 280E disallowance 4,318,695 7,648,632 Deferred tax adjustment (757,256 ) (585,809 ) Return to provision (1,543,140 ) - Valuation allowance 968,717 724,287 Change in state tax rate (186,076 ) - Uncertain tax position 3,790,133 - Other - (61,829 ) Total income tax expense $ 2,168,486 $ 1,774,609 |
Schedule of deferred income tax assets and liabilities | As at 31 July 2023 As at 31 July 2022 Deferred income tax asset Fixed assets $ 98,512 $ - Brand and license 605,980 559,032 Lease liabilities 595,496 342,437 Investments 263,188 126,395 Net operating loss carryforwards 775,060 276,739 Gross deferred tax assets 2,338,236 1,304,602 Less: valuation allowance (1,854,715 ) (854,143 ) Total deferred tax assets $ 483,521 $ 450,459 Deferred tax liabilities: Inventory $ - $ 541,689 Right-of-use assets 483,521 232,939 FY 21 & FY 22 481(a) Adjustment - - Fixed assets - 103,601 Total deferred tax liabilities $ 483,521 $ 878,229 Net deferred tax liabilities $ - $ (427,770 ) |
Schedule of net taxable income | As at 31 July 2023 As at 31 July 2022 Beginning year balance $ 966,992 $ 996,992 Increase in balance related to tax positions taken during current year 1,068,590 - Decrease in balance as a result of a lapse of the applicable statute of limitations (406,508 ) - Increase in balance related to tax positions taken during prior years 2,019,643 - Net deferred income tax liability $ 3,648,717 $ 996,992 |
Nature and Continuance of Ope_3
Nature and Continuance of Operations (Details) | 12 Months Ended |
Jul. 31, 2023 | |
BaM Body and Mind Dispensary NJ Inc [Member] | |
Date of acquisition or formation | 21 December 2022 |
Ownership | 100% |
Jurisdiction | New Jersey, USA |
NMG IL4, LLC ("NMG IL 4") [Member] | |
Date of acquisition or formation | 25 April 2023 |
Ownership | 100% |
Jurisdiction | Illinois, USA |
NMG CA C1, LLC ("NMG CA C1") [Member] | |
Date of acquisition or formation | 7 October 2020 |
Ownership | 100% |
Jurisdiction | California, USA |
NMG Ohio LLC | |
Date of acquisition or formation | 27 April 2017 |
Jurisdiction | Ohio, USA |
Ownership | 100% |
Nevada Medical Group LLC [Member] | |
Date of acquisition or formation | 14 November 2017 |
Ownership | 100% |
Jurisdiction | Nevada, USA |
NMG CA P1, LLC ("NMG CA P1") [Member] | |
Date of acquisition or formation | 7 January 2020 |
Ownership | 100% |
Jurisdiction | California, USA |
DEP Nevada Inc [Member] | |
Date of acquisition or formation | 10 August 2017 |
Ownership | 100% |
Jurisdiction | 100 |
NMG Long Beach LLC [Member] | |
Date of acquisition or formation | 18 December 2018 |
Ownership | 100% |
Jurisdiction | California, USA |
NMG San Diego LLC [Member] | |
Date of acquisition or formation | 30 January 2019 |
Ownership | 60% |
Jurisdiction | California, USA |
NMG OH 1, LLC | |
Date of acquisition or formation | 30 January 2020 |
Ownership | 100% |
Jurisdiction | Ohio, USA |
NMG OH P1, LLC [Member] | |
Date of acquisition or formation | 30 January 2020 |
Ownership | 100% |
Jurisdiction | Ohio, USA |
NMG MI 1, Inc | |
Date of acquisition or formation | 24 June 2021 |
Ownership | 100% |
Jurisdiction | Michigan, USA |
NMG MI C1 Inc. [Member] | |
Date of acquisition or formation | 24 June 2021 |
Ownership | 100% |
Jurisdiction | Michigan, USA |
NMG MI P1 Inc. [Member] | |
Date of acquisition or formation | 24 June 2021 |
Ownership | 100% |
Jurisdiction | Michigan, USA |
Canopy Monterey Bay, LLC [Member] | |
Date of acquisition or formation | 30 November 2021 |
Ownership | 100% |
Jurisdiction | California, USA |
Nature and Continuance of Ope_4
Nature and Continuance of Operations (Details Narrative) | May 31, 2004 |
Represents information related to Vocalscape, Inc. | |
Ownership | 100% |
Significant Accounting Polici_4
Significant Accounting Policies (Details) | 12 Months Ended |
Jul. 31, 2023 | |
Office Equipment [Member] | |
Estimated Useful Life | 7 years |
Cultivation equipment [Member] | |
Estimated Useful Life | 7 years |
Production Equipment [Member] | |
Estimated Useful Life | 7 years |
Kitchen equipment [Member] | |
Estimated Useful Life | 7 years |
Vehicles [Member] | |
Estimated Useful Life | 7 years |
Vault equipment [Member] | |
Estimated Useful Life | 7 years |
Leasehold Improvements [Member] | |
Estimated Useful Life | shorter of useful life or the term of the lease |
Significant Accounting Polici_5
Significant Accounting Policies (Details Narrative) | 12 Months Ended |
Jul. 31, 2023 shares | |
Dilutive options and warrants existed | 17,151,000 |
Conversion of convertible debentures | 31,472,877 |
Brands and licenses acquired by NMG SD | |
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 10 years |
Brands and licenses acquired by NMG LB and NMG OH 1 | |
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 10 years |
Brands and licenses acquired by Canopy | |
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life | 10 years |
Warrants [Member] | |
Dilutive options and warrants existed | 33,215,284 |
Financial Instruments (Details)
Financial Instruments (Details) - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
Financial Instruments | ||
Cash | $ 1,511,051 | $ 1,854,277 |
Convertible loan receivable | 1,700,411 | 1,250,000 |
Total financial assets at fair value | $ 3,211,462 | $ 3,104,277 |
Financial Instruments (Details
Financial Instruments (Details Narrative) | Jul. 31, 2023 USD ($) |
Financial Instruments | |
Working capital deficit | $ (1,606,967) |
Inventory (Details)
Inventory (Details) - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
Inventory | ||
Work in progress | $ 652,825 | $ 610,030 |
Finished goods | 604,519 | 1,961,244 |
Consumables | 1,053,257 | 1,308,726 |
Total | $ 2,310,601 | $ 3,880,000 |
Convertible loan receivable (De
Convertible loan receivable (Details Narrative) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Loan receivable | $ 1,250,000 | $ 1,250,000 |
Overhead expenses | 1,250,000 | |
Interests receivable | 294,000 | 222,000 |
Accrued interest income | 72,000 | 72,000 |
Loan receivable balance | $ 1,700,411 | |
Weighted Average Cost of Capital | 15% | |
Exercise price | $ 31,250 | |
Expected life of the options | 2 years 2 months 12 days | |
Description management agreement expiring date | four different maturity dates: (1) March 30, 2024, (2) March 30, 2025, (3) March 30, 2026 and (4) March 30, 2027, whereby each scenario is given 25% probability of occurring since the actual conversion date is uncertain. | |
Management fee (per month) | $ 350,766 | 559,937 |
Loan bears interest per month | $ 6,000 | |
Equity price | 38,335 | |
CCG | Convertible Loan Agreement | ||
Loan bears interest per month | $ 6,000 | |
Outstanding units percentage | 66.70% | |
Proceeds from fund construction | $ 1,250,000 | |
NMG [Member] | ||
Management fee (per month) | $ 6,000 | |
Percentage of monthly management fee | 66.67% | |
Management Agreement Expiring Date | 15 March 2024 | |
Risk-free interest rate | ||
Risk-free interest rate | 4.74% | |
Benchmark [Member] | ||
Expected volatility | 90% |
Loan receivable (Details Narrat
Loan receivable (Details Narrative) - CCG [Member] - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Loan receivables | $ 1,480,021 | $ 1,234,168 |
Net increase decrease in loan receivable | 938,206 | 391,168 |
Repayment of loan | 2,418,226 | 843,000 |
Other loan receivable | $ 148,221 | $ 789,984 |
Property and Equipment (Details
Property and Equipment (Details) | 12 Months Ended |
Jul. 31, 2023 USD ($) | |
Cost, beginning Balance | $ 5,980,290 |
Additions | 992,884 |
Impairment, cost | (4,493,721) |
Cost, ending balance | 2,479,453 |
Accumulated Depreciation, beginning balance | 2,260,005 |
Depreciation | 781,033 |
Impairment, Accumulated depreciation | (2,388,800) |
Accumulated Depreciation, ending balance | 652,238 |
Net Book Value, beginning balance | 3,720,285 |
Net Book Value, ending balance | 1,827,215 |
Office Equipment [Member] | |
Cost, beginning Balance | 333,689 |
Additions | 25,183 |
Impairment, cost | (295,980) |
Cost, ending balance | 62,892 |
Accumulated Depreciation, beginning balance | 61,761 |
Depreciation | 49,467 |
Impairment, Accumulated depreciation | (85,525) |
Accumulated Depreciation, ending balance | 25,705 |
Net Book Value, beginning balance | 37,187 |
Net Book Value, ending balance | 271,928 |
Cultivation equipment [Member] | |
Cost, beginning Balance | 466,110 |
Additions | 0 |
Impairment, cost | (466,110) |
Cost, ending balance | 0 |
Accumulated Depreciation, beginning balance | 318,856 |
Depreciation | 68,312 |
Impairment, Accumulated depreciation | (387,168) |
Accumulated Depreciation, ending balance | 0 |
Net Book Value, beginning balance | 147,254 |
Net Book Value, ending balance | 0 |
Production Equipment [Member] | |
Cost, beginning Balance | 581,335 |
Additions | 0 |
Impairment, cost | (345,650) |
Cost, ending balance | 235,685 |
Accumulated Depreciation, beginning balance | 290,729 |
Depreciation | 81,322 |
Impairment, Accumulated depreciation | (251,572) |
Accumulated Depreciation, ending balance | 120,479 |
Net Book Value, beginning balance | 290,606 |
Net Book Value, ending balance | 115,206 |
Kitchen equipment [Member] | |
Cost, beginning Balance | 63,102 |
Additions | 0 |
Impairment, cost | (41,050) |
Cost, ending balance | 22,052 |
Accumulated Depreciation, beginning balance | 29,880 |
Depreciation | 9,014 |
Impairment, Accumulated depreciation | (26,285) |
Accumulated Depreciation, ending balance | 12,609 |
Net Book Value, beginning balance | 33,222 |
Net Book Value, ending balance | 9,443 |
Vehicles [Member] | |
Cost, beginning Balance | 38,717 |
Additions | 0 |
Impairment, cost | (38,717) |
Cost, ending balance | 0 |
Accumulated Depreciation, beginning balance | 29,859 |
Depreciation | 5,531 |
Impairment, Accumulated depreciation | (35,390) |
Accumulated Depreciation, ending balance | 0 |
Net Book Value, beginning balance | 8,858 |
Net Book Value, ending balance | 0 |
Vault equipment [Member] | |
Cost, beginning Balance | 10,335 |
Additions | 0 |
Impairment, cost | (2,172) |
Cost, ending balance | 8,163 |
Accumulated Depreciation, beginning balance | 3,266 |
Depreciation | 1,476 |
Impairment, Accumulated depreciation | (1,828) |
Accumulated Depreciation, ending balance | 2,914 |
Net Book Value, beginning balance | 7,069 |
Net Book Value, ending balance | 5,249 |
Leasehold Improvements [Member] | |
Cost, beginning Balance | 4,487,002 |
Additions | 967,701 |
Impairment, cost | (3,304,042) |
Cost, ending balance | 2,150,661 |
Accumulated Depreciation, beginning balance | 1,525,654 |
Depreciation | 565,909 |
Impairment, Accumulated depreciation | (1,601,032) |
Accumulated Depreciation, ending balance | 490,531 |
Net Book Value, beginning balance | 2,961,348 |
Net Book Value, ending balance | $ 1,660,130 |
Property and Equipment (Detai_2
Property and Equipment (Details Narrative) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
General and administrative expenses | $ 93,248 | $ 223,764 |
Depreciation | 687,785 | 745,393 |
Impaired property and equipment | 992,884 | $ 264,513 |
NMG [Member] | ||
Impaired property and equipment | 2,104,921 | |
NMG MI 1, Inc | ||
Impairment Of Assets | 944,015 | |
Fair value of the asset | $ 0 |
Acquisitions (Details)
Acquisitions (Details) | 1 Months Ended |
Nov. 30, 2021 USD ($) | |
Promissory note | $ 2,300,000 |
Canopy Monterey Bay, LLC [Member] | |
Cash gross | 1,250,000 |
Promissory note | 2,300,000 |
Shares of common stock (Note 16) | 2,189,544 |
Contingent consideration | 100,000 |
Purchase consideration (Note 8) | 5,839,544 |
Cash | 378,503 |
Prepaid expenses | 241,449 |
Inventory | 630,039 |
Trade payable and accrued liabilities | (266,307) |
Income taxes payable | (1,229,213) |
Net assets acquired | (245,529) |
Brand and licenses | 1,240,000 |
Goodwill | 4,845,073 |
TOTAL | $ 5,839,544 |
Acquisitions (Details 1)
Acquisitions (Details 1) | 12 Months Ended |
Jul. 31, 2023 USD ($) | |
As Reported [Member] | |
Revenue | $ 23,372,823 |
Net loss | (28,228,104) |
Pro Forma [Member] | |
Revenue | 26,661,994 |
Net loss | $ (28,212,341) |
Acquisitions (Details 2)
Acquisitions (Details 2) - NMG IL4, LLC ("NMG IL 4") [Member] | Jul. 31, 2023 USD ($) |
Cash | $ 100,707 |
Prepaid and deposits | 70,230 |
Inventory | 194,075 |
Property and equipment | 918,492 |
Trade payable and accrued liabilities | (288,469) |
Net assets acquired | $ 995,035 |
Acquisitions (Details Narrative
Acquisitions (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | ||||||||
Apr. 25, 2023 | Jan. 17, 2023 | Dec. 21, 2022 | Jul. 31, 2022 | Nov. 30, 2021 | Jul. 31, 2023 | Jul. 31, 2022 | Jan. 31, 2023 | Oct. 31, 2022 | Jun. 17, 2022 | |
Promissory note | $ 2,300,000 | |||||||||
Loss on settlement | $ 100,000 | $ 503,179 | ||||||||
Consulting fee paid | $ 100,000 | $ 100,000 | ||||||||
Number of share issued | 16,301,694 | |||||||||
Common stock, shares issued | 16,666,667 | 113,668,613 | 146,636,974 | 113,668,613 | 16,301,694 | |||||
Lease liability and right-of-use assets | $ 170,000 | |||||||||
Acquisition destribition | the Company entered into an agreement with John Kim, our consultant in the State of Illinois for a two-year services related to licensing process for a total payment of $86,500 payable in tranches until 10 June 2023, as well as $15,000 per month to three designated individuals for two (2) years ending on 31 December 2024, and $5,000 per month to one additional individual for six (6) months ending 30 June 2023 for an aggregate total of $476,500 | The Company entered into a three-year strategic advisory services agreement with Bengal Capital dated 5 January 2023 (“Bengal Advisory Agreement”). The Company shall pay Bengal Capital $240,000 on each anniversary, of which $60,000 is to be paid in cash and $180,000 is to be paid in cash, common stock, or warrants to purchase shares of the Company’s common stock, in such proportions as are determined by the Company. The Company has accrued $140,000 under this agreement as of July 31, 2023. In addition, if the Company successfully obtains a cultivation license in New Jersey during the term of the Bengal Advisory Agreement, the Company will owe a fee of $1,000,000, which will be payable in the form of the Company’s common stock or a warrant to purchase shares of the Company’s common stock, in either case as requested by Bengal Capital. As of July 31, 2023, no license has been obtained and therefore the related fee has not been paid or accrued. | the Canopy acquisition agreements PA #1 and PA #2 on November 29, 2021, a Letter of Intent (“LOI”) was executed to engage the Sellers, Jayme Rivard and Cary Stiebel, as business consultants at a rate of $5,000 per month each, for 12 months beginning December 1, 2021. Subsequently, this LOI was amended on June 2, 2022 to extend the agreement until December 31, 2024 and for the Company to issue 100,000 stock options to purchase 100,000 shares of the Company 's common stock to Consultant, Mr. Stiebel, and 100,000 stock options to purchase 100,000 shares of the Company's common stock to Consultant, Jayme Rivard (collectively, the "Stock Options"). The exercise price for the Stock Options shall not be lower than | |||||||
First Amendment [Member] | ||||||||||
Common stock, shares issued | 16,666,667 | 2,238,806 | ||||||||
Purchase Price Reduced | 2,500,000 | $ 2,500,000 | ||||||||
Acquisition destribition | First Amendment (the “Effective Date”) and subject to compliance with the policies of the Canadian Securities Exchange (the “CSE”), which equates to 9,328,358 shares of common stock. The Company will also issue additional shares to Cary Stiebel equal to the difference between the amount of the shares of common stock of the Company that were issued by the Company to Mr. Stiebel on December 3, 2021 (the “PA #2 Shares”) and the amount of shares that Mr. Stiebel would have received had the VWAP for the PA #2 Shares been calculated as of the Effective Date (the “Additional PA #2 Shares”) which equates to 4,734,530 shares of common stock. Additionally, on the date that is eighteen (18) months (548 days) following the Effective Date of this First Amendment (the “Additional Share Issuance Date”) the Company will issue $100,000 worth of shares to the Sellers based on the ten (10) day VWAP and subject to compliance with the policies of the CSE, calculated as of the Additional Share Issuance Date. This $100,000 was recorded as consulting fees for the year ended 31 July 2022. Furthermore, DEP shall cause the Company to issue to Mr. Stiebel $300,000 worth of shares of common stock of the Company within three (3) days following the Effective Date of this First Amendment, and subject to compliance with the policies of the CSE (the “Additional True up Shares”) which equates to 2,238,806 shares of common stock | |||||||||
Purchase Price of agreement | $ 175,000 | 4,800,000 | ||||||||
Canopy Monterey Bay, LLC [Member] | ||||||||||
Promissory note | $ 2,300,000 | |||||||||
Ownership percentage | 100% | |||||||||
Common stock issued | $ 2,189,544 | |||||||||
Business acquisition payment | 1,250,000 | |||||||||
Business acquisition payment | $ 1,250,000 | |||||||||
Canopy Monterey Bay, LLC [Member] | Second Purchase Agreement | ||||||||||
Number of share issued | 2,728,156 | |||||||||
Ownership percentage | 100% | 100% | ||||||||
Common stock issued | $ 1,000,000 | |||||||||
Membership interests | 80% | |||||||||
Cash consideration deposited in escrow account | $ 80,000,000 | |||||||||
Promissory notes deposited in escrow account | $ 2,300,000 | |||||||||
Per share common stock issued | $ 0.3665 | |||||||||
Additonal number share issued | 100,000 | |||||||||
NMG IL4, LLC ("NMG IL 4") [Member] | Convertible Credit Facility Agreement [Member] | ||||||||||
Description for build out facility | DEP entered into a Convertible Credit Facility Agreement (the “Convertible Note”) with NMG IL 4 on December 26, 2019 to build-out the facility for up to $1,500,000 in lieu of converting into 99,900 membership units of NMG IL 4 | |||||||||
Ownership percentage | Upon receipt of the Illinois license, NMG IL 4 entered into a management agreement with Management Company and would be paid a management fee equal to 30% of net profits | |||||||||
NMG IL4, LLC ("NMG IL 4") [Member] | Membership Interest Purchase Agreement [Member] | ||||||||||
Description for build out facility | On April 25, 2023, DEP converted the Convertible Note for 99,900 units and purchased 100 units for $1,000 pursuant to the MIPA, after the opening of the Markham dispensary on or about April 25, 2023 | DEP also entered into a Membership Interest Purchase Agreement (the “MIPA”) on December 26, 2019 with both Tall Bird and Big Stone to purchase the remaining 100 units for $10 per unit | ||||||||
Crafted Plants NJ Corp [Member] | ||||||||||
Acquisition destribition | The Company also entered into a three-year strategic advisory services agreement with Bengal Impact Partners, LLC (“Bengal Capital”) dated 5 January 2023 (“Bengal Advisory Agreement”). The Company shall pay Bengal Capital $240,000 on each anniversary, of which $60,000 is to be paid in cash and $180,000 is to be paid in cash, common stock, or warrants to purchase shares of the Company’s common stock, in such proportions as are determined by the Company. In addition, if the Company successfully obtains a cultivation license in New Jersey during the term of the Bengal Advisory Agreement, the Company will owe a fee of $1,000,000, which will be payable in the form of the Company’s common stock or a warrant to purchase shares of the Company’s common stock, in either case as requested by Bengal Capital | |||||||||
Business acquisition payment | $ 995,035 | $ 50,000 | ||||||||
Business Acquisition late payment | $ 120,000 |
Intangible Assets Net (Details)
Intangible Assets Net (Details) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Brand | ||
Gross carrying amount | $ 370,000 | $ 425,000 |
Accumulated amortization | 0 | 0 |
Net carrying amount | 370,000 | 425,000 |
Licenses | ||
Gross carrying amount | 4,683,508 | 11,193,508 |
Accumulated amortization | (1,053,576) | (1,934,334) |
Net carrying amount | $ 3,629,932 | $ 9,259,174 |
Weighted average life (years) | 10 years | 10 years |
Total intangible assets | ||
Gross carrying amount | $ 5,053,508 | $ 11,618,508 |
Accumulated amortization | (1,053,576) | (1,934,334) |
Net carrying amount | $ 3,999,932 | $ 9,684,174 |
Intangible Assets Net (Details
Intangible Assets Net (Details 1) | Jul. 31, 2023 USD ($) |
Intangible Assets Net | |
2023 (remaining) | $ 371,631 |
2024 | 370,616 |
2025 | 370,616 |
2026 | 370,616 |
2027 | 370,616 |
2028 | 371,632 |
Thereafter | 1,774,821 |
Total | $ 3,629,932 |
Intangible Assets Net (Detail_2
Intangible Assets Net (Details Narrative) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Intangible Assets Net | ||
Amortization expenses | $ 1,021,260 | $ 266,753 |
Impairment loss | 55,000 | 42,000 |
License fees | $ 4,607,982 | $ 7,925,000 |
Related Party Balances and Tr_3
Related Party Balances and Transactions (Details) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Management Fees | $ 350,766 | $ 506,974 |
Corporate Secretary [Member] | ||
Management Fees | 56,647 | 87,748 |
President And Chief Executive Officer [Member] | ||
Management Fees | 212,505 | 284,533 |
Chief Financial Officer And Director [Member] | ||
Management Fees | $ 81,614 | $ 134,693 |
Related Party Balances and Tr_4
Related Party Balances and Transactions (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | |
Apr. 25, 2023 | Jul. 31, 2023 | Jul. 31, 2022 | |
Expiry date | 25 April 2028 | ||
Stock option granted | 4,050,000 | 395,526 | |
Exercise price | $ 0.065 | $ 0.45 | |
Due to Related Parties, Current | $ 93,481 | $ 163,862 | |
Chief Executive Officer [Member] | |||
Due to Related Parties, Current | 61,777 | 102,480 | |
Chief Financial Officer [Member] | |||
Due to Related Parties, Current | 0 | 10,780 | |
Corporate Secretary [Member] | |||
Due to Related Parties, Current | 0 | 18,898 | |
Related Party Transaction [Member] | |||
Expiry date | 25 April 2028 | ||
Stock option granted | 4,050,000 | ||
Description of vesting provision | vesting provisions such that 25% of the Options vest six (6) months from the date of grant, 25% of the Options vest twelve (12) months from the date of grant, 25% of the Options vest eighteen (18) months from the date of grant and 25% of the Options vest twenty-four (24) months from the date of grant | ||
Exercise price | $ 0.065 | ||
One [Member] | |||
Expiry date | 25 April 2028 | ||
Stock option granted | 5,323,000 | ||
Exercise price | $ 0.065 | ||
Cheif Operating Officer Member | |||
Due to Related Parties, Current | $ 31,704 | $ 31,704 |
Loans Payable and Convertible_3
Loans Payable and Convertible Debenture (Detail) - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
Loans Payable and Convertible Debenture | ||
Focus Growth loan | $ 6,666,667 | $ 6,666,667 |
Long Beach loan | 10,728 | 12,535 |
Secured promissory note | 2,300,000 | 2,300,000 |
Unsecured loan balance | 7,052 | 0 |
CCG loan | 148,221 | 0 |
Total principal amount | 9,132,668 | 8,979,202 |
Debt discount | 1,187,008 | 1,573,031 |
Outstanding loan balance | 7,945,660 | 7,406,171 |
Current portion | (166,001) | (12,535) |
Long-term portion | $ 7,779,659 | $ 7,393,636 |
Loans Payable and Convertible_4
Loans Payable and Convertible Debenture (Details 1) - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
BAM I, A Series of Bengal Catalyst Fund SPV, LP [Member] | ||
Total principal amount | $ 2,750,000 | $ 0 |
Mindset Value Fund LP One [Member] | ||
Total principal amount | 150,000 | 0 |
Mindset Value Wellness Fund LP One [Member] | ||
Total principal amount | 100,000 | 0 |
Convertible Debenture Financing [Member] | ||
Total principal amount | 3,000,000 | 0 |
Debt discount | (519,478) | 0 |
Outstanding balance, net | $ 2,480,522 | $ 0 |
Loans Payable and Convertible_5
Loans Payable and Convertible Debenture (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | ||||
Dec. 19, 2022 | Jun. 15, 2022 | Nov. 30, 2021 | Jul. 19, 2021 | Jul. 31, 2023 | Jul. 31, 2022 | |
Legal fees and other fees | $ 175,758 | |||||
Interest Expense | 159,476 | |||||
Unsecured loan | 10,728 | $ 12,535 | ||||
Warrants issued for services , amount | $ 1,037,146 | |||||
Warrants issued for services , shares | 4,800,000 | |||||
Combined fees | $ 175,758 | |||||
Origination discount, rate | 10% | |||||
Debt discount, loan | $ 1,883,901 | |||||
Description of second amendment to the Loan Agreement | the Company entered into a second amendment to the Loan Agreement (“Amendment No. 2 to Loan Agreement”) to extend the maturity date by one year to 19 July 2026. Additionally, Amendment No. 2 to Loan Agreement allows the outside date for the Company to draw on the delayed draw term loan of US$4.44 million to be extended from June 1, 2022 to March 31, 2023, whereby US$4 million in funds will be advanced to the Company. The ability of the Company to draw on the delayed draw term loan was subject to compliance with certain provisions in Loan Agreement including provision of a satisfactory budget approved at the sole discretion of the Lender. The Company did not draw or extend the Delayed Draw Term Loan and has expired. | |||||
Fair value of warrant, amount | $ 79,585 | |||||
Exercise price per share | $ 0.10 | |||||
Maturity date | Dec. 19, 2026 | |||||
Amortization of debt discount | ||||||
Amortization of debt discount | $ 519,478 | 0 | ||||
Lender [Member] | ||||||
Issued common stock purchase to warrants | 1,000,000 | |||||
Exercise cise | $ 0.16 | |||||
FG Agency Lending LLC [Member] | ||||||
Rate of interest | 13% | |||||
Maturity date | 19 July 2025 | |||||
Loan balance | $ 6,666,667 | |||||
Advance loan payble | $ 6,000,000 | |||||
Initial term loan description | The Company may draw upon the remaining face amount of $4,444,444 (the “Delayed Draw Term Loan”) upon providing a 30-day request to the Agent by 1 December 2021, whereby $4,000,000 will be advanced to the Company after applying the 10% origination discount | |||||
Additional Common stock purchase | 1,000,000 | |||||
Convertible Debenture Financing [Member] | ||||||
Interest Expense | 1,022,614 | |||||
Aggregate principal amount of debenture | $ 3,000,000 | |||||
Warrants to purchase | 15,000,000 | |||||
Rate of interest | 8% | |||||
Exercise price per share | $ 0.10 | |||||
Maturity date | Dec. 19, 2027 | |||||
Loan balance | 3,000,000 | |||||
Debt discount | (399,637) | |||||
Canopy Loan [Member] | ||||||
Unsecured loan | 7,052 | 0 | ||||
Rate of interest | 10% | |||||
Initial interest | 80% | |||||
Secured Promissory Note | $ 2,300,000 | |||||
Membership Interest | 80% | |||||
CCG loan [Member] | ||||||
Amount receivable | 148,221 | 0 | ||||
Advance loan payble | $ 148,221 | $ 0 | ||||
Warrants [Member] | ||||||
Exercise price per share | $ 0.40 | |||||
Aggregate purchase common stock shares | 8,000,000 | |||||
Acquire common stock shares | 4,800,000 | |||||
Escrowed shares | 3,200,000 | |||||
Escrowed shares price per share | $ 0.45 |
Operating leases (Details)
Operating leases (Details) | 12 Months Ended |
Jul. 31, 2023 USD ($) | |
Operating Leases | |
Operating cash flows from operating leases | $ 1,582,411 |
Weighted-average remaining lease term - operating leases | 7 years 10 days |
Weighted-average discount rate - operating leases | 12% |
Operating leases (Details 1)
Operating leases (Details 1) | Jul. 31, 2023 USD ($) |
Operating Leases | |
2024 | $ 2,114,388 |
2025 | 2,026,131 |
2026 | 1,978,981 |
2027 | 1,677,468 |
2028 and thereafter | 5,700,655 |
Total lease payments | 13,497,623 |
Less imputed interest | (4,538,918) |
Total | 8,958,705 |
Less current portion | 1,099,888 |
Long term portion | $ 7,858,817 |
Operating leases (Details 2)
Operating leases (Details 2) - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
Right-of-use Of assets | $ 4,329,634 | $ 3,271,685 |
NMG OH 1, LLC | ||
Right-of-use Of assets | 158,336 | 188,165 |
Lease liabilities | 162,552 | 191,529 |
NMG OH P1, LLC [Member] | ||
Right-of-use Of assets | 198,412 | 223,527 |
Lease liabilities | $ 202,618 | $ 226,303 |
Operating Leases (Details Narra
Operating Leases (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | ||||||||||||||||
Apr. 07, 2022 | Jan. 04, 2022 | Feb. 10, 2021 | Dec. 04, 2020 | Dec. 02, 2020 | Oct. 01, 2019 | Jun. 13, 2019 | May 07, 2019 | Dec. 02, 2018 | Aug. 02, 2018 | Nov. 10, 2017 | Jan. 10, 2017 | Feb. 15, 2022 | Apr. 23, 2021 | Jul. 31, 2023 | Jul. 31, 2022 | Oct. 31, 2021 | Jul. 01, 2021 | |
Periodic rent payable percentage | 3% | |||||||||||||||||
Amortization of right-of-use assets included in General and Administrative Expenses | $ 1,283,987 | |||||||||||||||||
Amortization of right-of-use assets included in Cost of Sales | $ 470,546 | 259,387 | ||||||||||||||||
Lease expense (Monthly) | 662,572 | |||||||||||||||||
Lease liability | 333,720 | $ 231,374 | ||||||||||||||||
Periodic rent payable amount | $ 9,000 | |||||||||||||||||
Accounting Standards Update 2016-02 [Member] | ||||||||||||||||||
Discount rate for present value of future lease payments | 12% | |||||||||||||||||
SJK Services, LLC [Member] | ||||||||||||||||||
Description for lease option to extend | we amended the lease agreement to include two additional options to extend the lease agreement for five years each and expanded the lease agreement to include 3413 | |||||||||||||||||
Description about lease rent | The guaranteed minimum monthly base rent was $7,316 + common area expenses for unit 3411, increased to $7,682 + common area expenses in January 2022, increased to $8,067 + common area expenses in January 2023, and is subject to a 5% increase on each anniversary date of the lease. The guaranteed monthly base rent for unit 3413 was $1,632 + common area expenses, increased to $1,681 + common area expenses on 1 April 2023 and is subject to a 3% increase on each anniversary date of the lease agreement | |||||||||||||||||
4 December, 2020 [Member] | NMG CA P1, LLC [Member] | ||||||||||||||||||
Lease expense (Monthly) | $ 6,028 | |||||||||||||||||
Description for lease option to extend | The lease agreement includes 3% annual base rent increases and two options to extend for five-years each. We amended the lease agreement on 27 January 2022, which extended the term to 31 December 2026 and rent commencement date. The base rent is $6,028 plus common area expenses for the first six month | |||||||||||||||||
1 October 2019 [Member] | NMG Ohio, LLC [Member] | ||||||||||||||||||
Lease expense (Monthly) | $ 4,200 | |||||||||||||||||
Description for lease option to extend | We have three options to extend the lease agreement for an additional three-year term. | |||||||||||||||||
Description about lease rent | The guaranteed minimum monthly rent is subject to 5% increase for each option period. On 1 September 2021, the lease agreement was assigned to NMG OH P1, LLC with the same terms. On 18 October 2022, NMG OH P1, LLC extended the lease agreement with MMCA Development, LLC for one additional term of three years | |||||||||||||||||
7 April 2022 [Member] | DEP Nevada, Inc [Member] | ||||||||||||||||||
Lease expense (Monthly) | $ 4,482 | |||||||||||||||||
Description for lease option to extend | The lease agreement includes 4% annual base rent increases and two options to extend for three years each | |||||||||||||||||
From 11 May 2021 [Member] | NMG Ohio, LLC [Member] | ||||||||||||||||||
Periodic rent payable amount | $ 4,000 | |||||||||||||||||
From 01 July, 2021 [Member] | NMG Ohio, LLC [Member] | ||||||||||||||||||
Periodic rent payable amount | $ 4,200 | |||||||||||||||||
December 1 , 2018 | SGSD LLC Member | ||||||||||||||||||
Description for lease option to extend | Under the terms of the assignment and first amendment to the original lease agreement dated 13 June 2019, we have three options to extend the lease and each option is for five years | |||||||||||||||||
Bonus provision | $ 1,000,000 | |||||||||||||||||
NMG Ohio LLC | ||||||||||||||||||
Description for lease option to extend | The Company has three options to extend the lease and each option is for three years. | |||||||||||||||||
Nevada Medical Group LLC [Member] | ||||||||||||||||||
Description for lease option to extend | We have two options to extend the lease for an additional three-year term and an option to purchase the property at any point during the initial term | expenses on 1 January 2021 and increased to $16,883 on 1 January 2022. | We have four options to extend the lease agreement and each option is for five years | |||||||||||||||
Description for change in rent | This lease includes two (2) options to extend for ten-years each. Concurrently with the execution of this lease, NMG IL 4 paid the sum of $92,234 consisting of twelve (12) months’ minimum rent in the sum of $84,960 plus one (1) fiscal year’s real estate taxes in the sum of $63,914 less the minimum rent credit in the sum of $56,640. On 12 October 2022, NMG IL 4 amended the lease agreement to relocate to certain premises containing approximately 3,600 square feet located at 3063 W. 159th Street, Markham, Illinois. The term of the lease as to relocated premises commenced on 12 October 2022 and as amended shall end on 31 January 2032. The Company acquired the rights to the lease agreement with NMG IL 4 on 25 April 2023 (Note 9). The base rent is currently $13,600 plus common area expenses until 31 January 2024 | 2% increase on each anniversary date of the lease | ||||||||||||||||
Nevada Medical Group LLC [Member] | From January 1, 2022 [Member] | ||||||||||||||||||
Periodic rent payable amount | $ 13,663 | |||||||||||||||||
Description for change in rent | 3% increase on each anniversary date of the lease. | |||||||||||||||||
Nevada Medical Group LLC [Member] | From 09 May, 2022 [Member] | ||||||||||||||||||
Periodic rent payable amount | $ 13,936 | |||||||||||||||||
Nevada Medical Group LLC [Member] | From May 1, 2022 [Member] | ||||||||||||||||||
Periodic rent payable amount | $ 6,478 | $ 15,913 | ||||||||||||||||
Nevada Medical Group LLC [Member] | From July 31, 2022 [Member] | ||||||||||||||||||
Periodic rent payable amount | $ 6,780 | $ 16,390 | ||||||||||||||||
Nevada Medical Group LLC [Member] | 7 May 2019 | ||||||||||||||||||
Description about lease rent | The guaranteed minimum monthly rent is subject to a $0.03 per square foot, per month, increase on each anniversary date of the lease for years one through three of the term and $0.04 per square foot, per month, increase on each anniversary date of the lease for years four through five of the term | The guaranteed monthly rent is subject to a 6% increase on each anniversary date of the lease, based on increases in the Consumer Price Index for San Diego County. The lease contains a sale bonus provision of $1,000,000 or 10% of the purchase price of the entire business | ||||||||||||||||
NMG MI 1 [Member] | ||||||||||||||||||
Lease expense (Monthly) | $ 5,000 | |||||||||||||||||
Issued common share upon achieving certain milestones | $ 150,000 | |||||||||||||||||
Accrued milestone | 151,480 | |||||||||||||||||
Settlement of accrued milestone by shares | 75,000 | |||||||||||||||||
Percent of common stock issued after receipt of local commercial license | 25% | |||||||||||||||||
Percent of common stock issued after passing final inspection | 25% | |||||||||||||||||
Percent of common stock issued after receipt of local commercial Adult use of license | 25% | |||||||||||||||||
Percent of common stock issued after MI 1passing final inspection | 25% | |||||||||||||||||
NMG MI P1 [Member] | ||||||||||||||||||
Amortization of right-of-use assets included in Cost of Sales | 470,546 | |||||||||||||||||
Lease expense (Monthly) | $ 7,500 | $ 23,474 | ||||||||||||||||
Lease liability | 479,029 | $ 239,173 | ||||||||||||||||
Description for lease option to extend | The lease agreement includes 2% annual base rent increases and three options to extend for five-years each. | The lease agreement includes a rent abatement period, 3% annual base rent increases and two options to extend for five-years each | ||||||||||||||||
Issued common share upon achieving certain milestones | $ 400,000 | |||||||||||||||||
Common share issued on receiving local and state commercial marihuana processing licenses | 200,000 | |||||||||||||||||
Common share issued on receiving operating permit to begin commercial marihuana processing operation | $ 200,000 | $ 22,790 | ||||||||||||||||
NMG MI C1 [Member] | ||||||||||||||||||
Lease liability | $ 1,437,086 | |||||||||||||||||
Description for lease option to extend | The lease agreement includes 2% annual base rent increases and three options to extend for five-years each | |||||||||||||||||
Issued common share upon achieving certain milestones | $ 22,500 | |||||||||||||||||
Common share issued on receiving local and state commercial marihuana cultivation licenses | 200,000 | |||||||||||||||||
Common share issued on receiving local operating permit to begin commercial marihuana cultivation operation | 200,000 | |||||||||||||||||
Common share issued on receiving local and state commercial marihuana retail licenses | 100,000 | |||||||||||||||||
Common share issued on Common share issued on receiving local operating permit to begin commercial marihuana retail operation | $ 100,000 | |||||||||||||||||
Simone Investment Group, LLC [Member] | ||||||||||||||||||
Description for lease option to extend | (i) twelve months from the Lease Commencement Date, (ii) upon issuance to Tenant of the Class 5 Cannabis Retail License by the Commission plus thirty days, or (iii) the date when the Tenant opens for business; and Phase II of ten years from the earlier of (i) the date when the Tenant opens for business, (ii) twelve months from 15 February 2022, or (iii) thirty days after the issuance to Tenant of the Class 5 Cannabis Retail License by the Commission. Tenant has four options to extend the lease and each option is for five years. On 21 December 2022, the Company acquired the rights to the lease agreement from the merger with CraftedPlants NJ Corp. for consideration of $170,000 (Note 9). The rent for Phase I was $10,000 per month for the first eight months and increased to $14,000 per month on the nineth month. The rent for Phase II was $25,146 annually for the first five years and increased to $29,583 annually on the sixth year | |||||||||||||||||
Rent expense description | 7,500 | 14325 | The rent for Phase I was $10,000 per month for the first eight months and increased to $14,000 per month on the nineth month. The rent for Phase II was $25,146 annually for the first five years and increased to $29,583 annually on the sixth year. |
Capital Stock (Details)
Capital Stock (Details) - CAD ($) | 1 Months Ended | 12 Months Ended | |
Apr. 25, 2023 | Jul. 31, 2023 | Jul. 31, 2022 | |
Granted, number of share | 4,050,000 | 395,526 | |
Outstanding number of share, ending balane | 17,151,000 | ||
Stock options [Member] | |||
Outstanding number of share, beginning balance | 9,453,000 | 9,855,000 | |
Granted, number of share | 9,773,000 | 848,000 | |
Cancelled, number of share | (1,250,000) | ||
Expired, number of share | 2,075,000 | ||
Outstanding number of share, ending balane | 17,151,000 | 9,453,000 | |
Vested and fully exercisableoption outstanding | 12,989,000 | ||
Weighted average exercise price outstanding, beginning balance | $ 0.67 | $ 0.71 | |
Weighted average exercise price, granted | 0.07 | 0.37 | |
Weighted average exercise price, cancelled | 0.70 | ||
Weighted average exercise price, Vested and fully exercisable | 0.41 | ||
Weighted average exercise price, Expired | 0.64 | ||
Weighted average exercise price outstanding, ending balane | $ 0.33 | $ 0.67 | |
Weighted average contractual term remaining (in years) | 2 years 1 month 9 days | 2 years 9 months 3 days | |
Weighted average contractual term remaining (in year) | 3 years 1 month 28 days | 2 years 1 month 10 days | |
Weighted average contractual term remaining (in years), Vested and fully exercisable | 2 years 8 months 8 days | ||
Aggregate intrinsic value outstanding, beginning balance | $ 0 | $ 0 | |
Aggregate intrinsic value outstanding, ending balane | $ 0 |
Capital Stock (Details 1)
Capital Stock (Details 1) | 12 Months Ended |
Jul. 31, 2023 $ / shares shares | |
Number of options outstanding | 17,151,000 |
Number of options exercisable | 12,989,000 |
Range 1 [Member] | |
Number of options outstanding | 775,000 |
Number of options exercisable | 775,000 |
Exercise price | $ / shares | $ 0.57 |
Expire date | 10 December 2023 |
Range Two [Member] | |
Number of options outstanding | 1,600,000 |
Number of options exercisable | 1,600,000 |
Exercise price | $ / shares | $ 0.88 |
Expire date | 21 August 2024 |
Range Three [Member] | |
Number of options outstanding | 250,000 |
Number of options exercisable | 250,000 |
Exercise price | $ / shares | $ 0.93 |
Expire date | 1 October 2024 |
Range Four [Member] | |
Number of options outstanding | 200,000 |
Number of options exercisable | 200,000 |
Exercise price | $ / shares | $ 0.88 |
Expire date | 23 January 2025 |
Range Five [Member] | |
Number of options outstanding | 250,000 |
Number of options exercisable | 250,000 |
Exercise price | $ / shares | $ 0.405 |
Expire date | 1 March 2025 |
Range Six [Member] | |
Number of options outstanding | 1,375,000 |
Number of options exercisable | 1,375,000 |
Exercise price | $ / shares | $ 0.67 |
Expire date | 30 April 2025 |
Range Seven [Member] | |
Number of options outstanding | 350,000 |
Number of options exercisable | 350,000 |
Exercise price | $ / shares | $ 0.88 |
Expire date | 21 August 2024 |
Range Eight [Member] | |
Number of options outstanding | 150,000 |
Number of options exercisable | 150,000 |
Exercise price | $ / shares | $ 0.61 |
Expire date | 10 December 2023 |
Range Nine [Member] | |
Number of options outstanding | 80,000 |
Number of options exercisable | 80,000 |
Exercise price | $ / shares | $ 0.57 |
Expire date | 10 December 2023 |
Range Ten [Member] | |
Number of options outstanding | 1,250,000 |
Number of options exercisable | 1,250,000 |
Exercise price | $ / shares | $ 0.68 |
Expire date | 6 March 2026 |
Range Eleven [Member] | |
Number of options outstanding | 250,000 |
Number of options exercisable | 250,000 |
Exercise price | $ / shares | $ 0.65 |
Expire date | 5 April 2024 |
Range Twelve [Member] | |
Number of options outstanding | 448,000 |
Number of options exercisable | 336,000 |
Exercise price | $ / shares | $ 0.44 |
Expire date | 30 November 2026 |
Range Thirteen [Member] | |
Number of options outstanding | 200,000 |
Number of options exercisable | 200,000 |
Exercise price | $ / shares | $ 0.44 |
Expire date | 30 November 2024 |
Range Fourteen [Member] | |
Number of options outstanding | 200,000 |
Number of options exercisable | 200,000 |
Exercise price | $ / shares | $ 0.15 |
Expire date | 8 July 2027 |
Range Fifteen [Member] | |
Number of options outstanding | 4,050,000 |
Exercise price | $ / shares | $ 0.065 |
Expire date | 25 April 2028 |
Range Sixteen [Member] | |
Number of options outstanding | 5,723,000 |
Number of options exercisable | 5,723,000 |
Exercise price | $ / shares | $ 0.065 |
Expire date | 25 April 2028 |
Capital Stock (Details 2)
Capital Stock (Details 2) - Options [Member] | 12 Months Ended |
Jul. 31, 2023 | |
Expected life of the options | 2 years 9 months 3 days |
Expected volatility | 103% |
Expected dividend yield | 0% |
Risk-free interest rate | 3.27% |
Capital Stock (Details 3)
Capital Stock (Details 3) - $ / shares | 1 Months Ended | 12 Months Ended | |
Apr. 25, 2023 | Jul. 31, 2023 | Jul. 31, 2022 | |
Number of warrants Issued | 4,050,000 | 395,526 | |
Share Purchase Warrants [Member] | |||
Number of warrants Outstanding beginning balance | 18,215,284 | 17,215,284 | |
Number of warrants Issued | 15,000,000 | 1,000,000 | |
Number of warrants Expired/Cancelled | 12,415,284 | ||
Number of warrants outstanding ending balance | 20,800,000 | 18,215,284 | |
Weighted Average Exercise Price Outstanding balance | $ 1.16 | $ 1.21 | |
Weighted Exercise Price Issued | 0.10 | 0.16 | |
Weighted Exercise Price Expired/Cancelled | 1.49 | ||
Weighted Average Exercise Price ending balance | $ 0.23 | $ 1.16 |
Capital Stock (Details 4)
Capital Stock (Details 4) - Share Purchase Warrants [Member] | 12 Months Ended |
Jul. 31, 2023 | |
Expected life of the options | 4 years |
Expected volatility | 107% |
Expected dividend yield | 0% |
Risk-free interest rate | 3.03% |
Capital Stock (Details 5)
Capital Stock (Details 5) | 1 Months Ended | 12 Months Ended | |||
Apr. 25, 2023 | Jul. 31, 2023 $ / shares shares | Jul. 31, 2022 $ / shares shares | Jul. 31, 2023 $ / shares shares | Jul. 31, 2022 $ / shares shares | |
Number of warrants outstanding and exercisable | 20,800,000 | 18,215,284 | 20,800,000 | 18,215,284 | |
Warrants price per share | $ / shares | $ 0.23 | $ 1.16 | |||
ExpiryDate | 25 April 2028 | ||||
One Range [Member] | |||||
Number of warrants outstanding and exercisable | 4,800,000 | 11,780,134 | 4,800,000 | 11,780,134 | |
Warrants price per share | (per share) | $ 0.40 | $ 1.50 | |||
ExpiryDate | 19 July 2025 | 17 May 2023 | |||
Two Range [Member] | |||||
Number of warrants outstanding and exercisable | 15,000,000 | 635,150 | 15,000,000 | 635,150 | |
Warrants price per share | (per share) | $ 0.10 | $ 1.25 | |||
ExpiryDate | 19 December 2026 | 16 May 2023 | |||
Three Range [Member] | |||||
Number of warrants outstanding and exercisable | 1,000,000 | 4,800,000 | 1,000,000 | 4,800,000 | |
Warrants price per share | $ / shares | $ 0.16 | $ 0.40 | |||
ExpiryDate | 14 June 2027 | 19 July 2025 | |||
Four Range [Member] | |||||
Number of warrants outstanding and exercisable | 1,000,000 | 1,000,000 | |||
Warrants price per share | $ / shares | $ 0.16 | ||||
ExpiryDate | 14 June 2027 |
Capital Stock (Details Narrativ
Capital Stock (Details Narrative) - USD ($) | 1 Months Ended | 9 Months Ended | 12 Months Ended | |||||
Apr. 25, 2023 | Apr. 30, 2022 | Jul. 31, 2023 | Jul. 31, 2022 | Dec. 21, 2022 | Dec. 07, 2022 | Oct. 31, 2022 | Sep. 21, 2021 | |
Common shares in escrow | 146,636,974 | 113,668,613 | 16,666,667 | 16,301,694 | ||||
Issuance of aggregate common stock shares | 16,301,694 | 319,149 | ||||||
Common stcok shares held in escrow | 2,238,806 | |||||||
Capital stock, par value | $ 0.0001 | $ 0.0001 | ||||||
Number of warrants Issued | 4,050,000 | 395,526 | ||||||
Exercise price | $ 0.065 | $ 0.45 | ||||||
Expiry date | 25 April 2028 | |||||||
Share based compensation expense | $ 386,327 | $ 270,693 | $ 435,266 | |||||
Capital stock, shares authorized | 900,000,000 | 900,000,000 | ||||||
directors, officers, employees and consultants [Member] | ||||||||
Number of warrants Issued | 5,723,000 | |||||||
Exercise price | $ 0.065 | |||||||
Expiry date | 25 April 2028 | |||||||
Share Purchase Warrants [Member] | ||||||||
Warrants issued | 3,200,000 | |||||||
Issued warrants in connection with issuance of convertible debentures | 15,000,000 | |||||||
Exercise price per warrant Share | $ 0.10 | |||||||
Fair value of warrants, share | 15,000,000 | |||||||
Fair value of warrants, value | $ 592,159 | |||||||
Number of warrants Issued | 15,000,000 | 1,000,000 | ||||||
September 2021 | ||||||||
Common shares in escrow | 2,681,006 | |||||||
Number of share issued | 2,728,156 | |||||||
Lease agreement for a premises in Muskegon, Michigan [Member] | ||||||||
Common stock shares issued | 238,929 | |||||||
Common stock shares issued under agreement | 1,304,601 | |||||||
Merger Agreement With CraftedPlants [Member] | ||||||||
Common shares in escrow | 16,666,667 |
Segmented Information and Maj_3
Segmented Information and Major Customers (Details) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Revenue | $ 22,819,983 | $ 23,372,823 |
Net loss before taxes | (18,154,204) | |
Retail [Member] | ||
Revenue | 17,749,542 | |
Net loss before taxes | (5,321,539) | |
Wholesale [Member] | ||
Revenue | 5,070,441 | |
Net loss before taxes | (5,520,602) | |
All others [Member] | ||
Net loss before taxes | $ (7,312,063) |
Supplemental Disclosures with_3
Supplemental Disclosures with Respect to Cash Flows (Details) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Supplemental Disclosures with Respect to Cash Flows | ||
Cash paid during the year for interest | $ 1,037,208 | $ 876,364 |
Cash paid during the period for income taxes | $ 25,663 | $ 3,436,572 |
Supplemental Disclosures with_4
Supplemental Disclosures with Respect to Cash Flows (Details Narrative) | Sep. 21, 2021 shares |
Lease agreement for a premises in Muskegon, Michigan [Member] | |
Common stock shares issued | 238,929 |
Common stock shares issued under agreement | 1,304,601 |
Lease agreement for a premises in Manistee, Michigan [Member] | |
Common stock shares issued under agreement | 1,304,601 |
Commitments and Contingencies (
Commitments and Contingencies (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | |||||
Jul. 03, 2019 | Jan. 17, 2023 | Dec. 21, 2022 | Jul. 31, 2022 | Jul. 31, 2023 | Oct. 31, 2022 | Aug. 12, 2019 | |
Total revised committed payments | $ 733,150 | ||||||
Common shares in escrow | 16,666,667 | 113,668,613 | 146,636,974 | 16,301,694 | |||
Consultation fee | $ 100,000 | $ 100,000 | |||||
Acquisation description | the Company entered into an agreement with John Kim, our consultant in the State of Illinois for a two-year services related to licensing process for a total payment of $86,500 payable in tranches until 10 June 2023, as well as $15,000 per month to three designated individuals for two (2) years ending on 31 December 2024, and $5,000 per month to one additional individual for six (6) months ending 30 June 2023 for an aggregate total of $476,500 | The Company entered into a three-year strategic advisory services agreement with Bengal Capital dated 5 January 2023 (“Bengal Advisory Agreement”). The Company shall pay Bengal Capital $240,000 on each anniversary, of which $60,000 is to be paid in cash and $180,000 is to be paid in cash, common stock, or warrants to purchase shares of the Company’s common stock, in such proportions as are determined by the Company. The Company has accrued $140,000 under this agreement as of July 31, 2023. In addition, if the Company successfully obtains a cultivation license in New Jersey during the term of the Bengal Advisory Agreement, the Company will owe a fee of $1,000,000, which will be payable in the form of the Company’s common stock or a warrant to purchase shares of the Company’s common stock, in either case as requested by Bengal Capital. As of July 31, 2023, no license has been obtained and therefore the related fee has not been paid or accrued. | the Canopy acquisition agreements PA #1 and PA #2 on November 29, 2021, a Letter of Intent (“LOI”) was executed to engage the Sellers, Jayme Rivard and Cary Stiebel, as business consultants at a rate of $5,000 per month each, for 12 months beginning December 1, 2021. Subsequently, this LOI was amended on June 2, 2022 to extend the agreement until December 31, 2024 and for the Company to issue 100,000 stock options to purchase 100,000 shares of the Company 's common stock to Consultant, Mr. Stiebel, and 100,000 stock options to purchase 100,000 shares of the Company's common stock to Consultant, Jayme Rivard (collectively, the "Stock Options"). The exercise price for the Stock Options shall not be lower than | ||||
Acquisation amendment description | a) $30,000 due 10 May 2023, $10,000 payable in each month of June, September, November 2023, and $15,000 each month for the period from January 2024 to February 2025, to John Kim; b) $7,500 per month to John Kim for May and June 2023, and $5,000 per month for remaining months until 31 December 2024; c) $5,000 or $5,833 per month to three designated individuals until 31 December 2024, except for certain months with variable payments ranging from $7,500 to $15,833. | ||||||
GLDH [Member] | |||||||
Ownership percentage | 100% | ||||||
Investment purchase price | $ 6,700,000 | ||||||
Amount to be paid in common shares | $ 1,500,000 | ||||||
Share price per share | $ 0.7439 | ||||||
Maximum number of common shares | 2,681,006 | ||||||
Common shares in escrow | 2,681,006 |
Other Agreement (Details Narrat
Other Agreement (Details Narrative) | Jul. 31, 2023 |
Other Agreements | |
Lottery with a pool of applicants | 85% |
Discontinued Operations and A_3
Discontinued Operations and Assets Held for Sale (Details) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Discontinued Operations and Assets Held for Sale | ||
Sales | $ 7,364,410 | $ 8,265,339 |
Cost of sales | (4,398,644) | (4,768,324) |
Gross profit | 2,965,766 | 3,497,015 |
Operating expenses | (2,479,390) | (2,504,514) |
Other items | (13,406) | (60,928) |
Impairment of Michigan assets | (944,015) | 0 |
Total Operating Expenses | (3,436,811) | (2,565,442) |
Income (loss) from discontinued operations before income taxes | (471,045) | 931,573 |
Income tax expense | (82,744) | (744,323) |
Net income (loss) from discontinued operations | $ (553,789) | $ 187,250 |
Discontinued Operations and A_4
Discontinued Operations and Assets Held for Sale (Details 1) - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
Discontinued Operations and Assets Held for Sale | ||
Cash | $ 164,882 | $ 385,176 |
Accounts receivable, net | 20,335 | 36,740 |
Prepaids | 238,756 | 217,566 |
Inventory | 208,794 | 314,570 |
Property and equipment, net | 1,143,818 | 1,920,249 |
Operating lease right-of-use assets | 356,748 | 890,962 |
Brand and licenses, net | 1,897,295 | 2,177,141 |
Total assets associated with discontinued operations | 4,030,628 | 5,942,404 |
Accounts payables and accrued liabilities | 214,129 | 307,415 |
Operating lease liabilities | 365,170 | 771,667 |
Total liabilities associated with discontinued operations | $ 579,299 | $ 1,079,082 |
Discontinued Operations and A_5
Discontinued Operations and Assets Held for Sale (Details 2) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Beggining balance | $ 5,942,404 | $ 3,939,208 |
Ending balance | 4,030,628 | |
Ongoing activity from discontinued operations | (732,982) | (405,609) |
Transfer In | 2,408,805 | |
Disposition | 1,178,794 | |
Available for Sale Subsidiaries [Member] | ||
Beggining balance | 4,763,610 | 3,939,208 |
Ending balance | 4,030,628 | |
Ongoing activity from discontinued operations | (732,982) | (405,609) |
Transfer In | 1,230,011 | |
Disposition | 0 | |
Discontinued Operations [Member] | ||
Beggining balance | 1,178,794 | 0 |
Ending balance | 0 | |
Ongoing activity from discontinued operations | 0 | 0 |
Transfer In | $ 1,178,794 | |
Disposition | $ (1,178,794) |
Discontinued Operations and A_6
Discontinued Operations and Assets Held for Sale (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | |
Sep. 05, 2023 | Oct. 17, 2023 | Jul. 31, 2023 | |
Discontinued Operations and Assets Held for Sale | |||
Initial total consideration | $ 8,225,000 | ||
Impairment loss held for sale | $ 944,015 | ||
Closing plus | $ 7,975,000 | ||
Deposit | $ 250,000 | ||
Purchaser price | $ 2,000,000,000,000 | ||
Purchase Agreement | $ 1,000,000 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Current | ||
Federal | $ 2,588,522 | $ 1,540,516 |
State | 7,471 | 61,153 |
Total Current | 2,595,993 | 1,601,669 |
Deferred | ||
Federal | 427,507 | 4,787 |
State | 0 | 168,153 |
Total Deferred | (427,507) | 172,940 |
Total (benefit) expense for income taxes | $ 2,168,486 | $ 1,774,609 |
Income Taxes (Details 1)
Income Taxes (Details 1) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Income Taxes | ||
Net loss for the year before income tax | $ (18,154,204) | $ (26,640,745) |
Federal and state income tax rates | 21% | 21% |
Expected income tax recovery | $ (3,806,994) | $ (5,594,555) |
State taxes | (615,593) | (474,933) |
Stock options | 0 | 118,816 |
IRC 280E disallowance | 4,318,695 | 7,648,632 |
Deferred tax adjustment | (757,256) | (585,809) |
Return to provision | (1,543,140) | 0 |
Valuation Allowance | 968,717 | 724,287 |
Change in tax rates | (186,076) | 0 |
Uncertain tax position | 3,790,133 | 0 |
Other | 0 | (61,829) |
Total income tax expense | $ 2,168,486 | $ 1,774,609 |
Income Taxes (Details 2)
Income Taxes (Details 2) - USD ($) | Jul. 31, 2023 | Jul. 31, 2022 |
Deferred income tax asset | ||
Fixed assets | $ 98,512 | $ 0 |
Brand and license | 605,980 | 559,032 |
Lease liabilities | 595,496 | 342,437 |
Investments | 263,188 | 126,395 |
Net operating loss carryforwards | 775,060 | 276,739 |
Gross deferred tax assets | 2,338,236 | 1,304,602 |
Deferred tax allowance | (1,854,715) | (854,143) |
Total deferred tax assets | 483,521 | 450,459 |
Deferred tax liabilities: | ||
Inventory | 0 | 541,689 |
Right-of-use assets | 483,521 | 232,939 |
Fixed assets | 0 | 103,601 |
Total deferred tax liabilities | 483,521 | 878,229 |
Net deferred tax liabilities | $ 0 | $ (427,770) |
Income Taxes (Details 3)
Income Taxes (Details 3) - USD ($) | 12 Months Ended | |
Jul. 31, 2023 | Jul. 31, 2022 | |
Income Taxes | ||
Net deferred income tax liability, Beginning year balance | $ 966,992 | $ 996,992 |
Increase in balance related to tax positions taken during current year | 1,068,590 | 0 |
Decrease in balance as a result of a lapse of the applicable statute of limitations | (406,508) | 0 |
Increase in balance related to tax positions taken during prior years | 2,019,643 | 0 |
Net deferred income tax liability, Ending Year Balances | $ 3,648,717 | $ 996,992 |
Income Taxes (Details Narrative
Income Taxes (Details Narrative) | 12 Months Ended |
Jul. 31, 2023 USD ($) | |
Income Taxes | |
Unrecognized tax benefits interest | $ 591,087 |
Unrecognized tax benefits effective tax rate | 3,648,717 |
Net operating loss | 90,929,330,000 |
Valuation Allowance | 1,000,572 |
Loss on impairment of goodwill, intangible assets | $ 9,370,092 |
Subsequent Events (Details Narr
Subsequent Events (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | ||
Sep. 05, 2023 | Oct. 17, 2023 | Jul. 31, 2023 | Jul. 31, 2022 | |
Net proceeds | $ 22,819,983 | $ 23,372,823 | ||
Subsequent Event [Member] | ||||
Cash consideration deposited in escrow account | $ 1,000,000 | |||
Total consideration | $ 8,225,000 | |||
Bonus Payment | $ 2,500,000 | |||
Description for deposit | US$7,975,000 on closing plus US$250,000 deposit upon signing of the EPA) (the “Initial Purchase Price”) in cash to DEP Nevada, which Initial Purchase Price is subject to a working capital adjustment and other customary adjustments pursuant to the EPA to be calculated within 365 days of the Closing Date (the “Final Purchase Price”) | |||
Net proceeds | $ 2,000,000 | |||
Debt | $ 7,330,000 |